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Resumo 
 
O género Burkholderia é constituído por um grupo de bactérias gram-negativas que 
apresentam uma elevada diversidade metabólica e que podem ser encontradas em diversos 
nichos ecológicos tais como o solo e a água, em associação com plantas ou como agentes 
infeciosos de animais e humanos. Estudos fenotípicos e genotípicos mostraram que algumas 
destas bactérias apresentavam uma elevada semelhança entre si e foram portanto agrupadas 
num complexo denominado “Burkholderia cepacia complex” (Bcc). Apesar das bactérias 
deste complexo serem praticamente inofensivas para indivíduos saudáveis podem infetar 
pacientes com doenças pulmonares crónicas como a fibrose quística, bem como indivíduos 
com o sistema imunitário debilitado. 
A fibrose quística é causada por mutações no gene codificante de uma proteína 
transportadora do ião cloreto, conduzindo a uma desregulação da produção de muco nos 
pulmões, a uma maior dificuldade na sua remoção e, consequentemente, a uma maior 
probabilidade de serem colonizados por microrganismos patogénicos e patogénicos 
oportunistas. A presença nos pulmões dos pacientes com fibrose quística de bactérias do 
complexo Bcc multi-resistentes a antibióticos contribui para o estabelecimento de infeções 
pulmonares crónicas com declínio da função pulmonar que, nos casos mais severos, podem 
resultar em septicémias e muitas vezes na morte do paciente. 
A patogenicidade das bactérias do complexo Bcc está relacionada com diversos fatores 
de virulência, entre os quais o exopolissacárido (EPS) cepaciano. O cepaciano é comumente 
produzido dentro do género Burkholderia e confere às bactérias um morfotipo mucóide. As 
funções do EPS variam consoante o organismo podendo estar relacionadas com a 
patogenicidade da bactéria e com a sua capacidade de adaptação a diferentes ambientes. 
Durante as infeções prolongadas com bactérias do complexo Bcc pode acontecer uma 
variação de morfotipo que se caracteriza maioritariamente pela conversão de células mucóides 
em não-mucóides e que se pensa ser bastante importante para a virulência e adaptação destas 
ao ambiente pulmonar. Trabalhos anteriores compararam dois isolados clonais da espécie B. 
multivorans isolados sequencialmente de um paciente com fibrose quística em que o primeiro 
é mucóide e o segundo é não-mucóide. A caracterização desses dois isolados permitiu 
observar que as células mucóides e não-mucóides apresentaram diferenças fenotípicas e de 
expressão génica relacionadas com a motilidade, a formação de biofilmes e a resistência aos 
antibióticos. O isolado não-mucóide revelou-se também menos virulento do que o isolado 
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mucóide quando se usaram larvas do insecto Galleria mellonella como modelo de infeção. 
Foi ainda observado que o isolado mucóide tinha a capacidade de originar variantes não-
mucóides quando era exposto a diversas condições de stress, incluindo a limitação de 
nutrientes, a presença de antibióticos, a elevada concentração de sal e de compostos indutores 
de stress oxidativo, a temperaturas sub- e supra-ótimas, entre outros. Surgiu então a hipótese 
desta possível variação de morfotipo também ocorrer noutras espécies de Burkolderia 
pertencentes ou não ao complexo Bcc e provenientes de diferentes nichos ecológicos.  
Neste trabalho estudou-se então a variação do morfotipo mucóide a não-mucóide de 
diferentes espécies do género Burkholderia quando estas são sujeitas a limitação de nutrientes 
e à presença do antibiótico ciprofloxacina. Foram estudadas 16 estirpes de Burkholderia 
incluindo 9 isolados clínicos pertencentes ao complexo Bcc (B. multivorans D2095; B. 
cepacia IST408; B. cenocepacia J415; B. stabilis LMG18888; B. vietnamiensis PC259; B. 
ambifaria CEP0958; B. dolosa CEP0743; e B. anthina FC0974 e FC0967), 5 isolados 
ambientais também pertencentes ao complexo Bcc (B. multivorans ATCC 17616; B. cepacia 
ATCC 17759; B. stabilis LMG14086; B. ambifaria AMMD; e B. anthina J2552) e dois 
isolados ambientais não pertencentes ao complexo Bcc (B. phymatum STM815 e B. 
xenovorans LB400). Observou-se que tanto as estirpes clínicas como as ambientais do 
complexo Bcc ou não-Bcc tinham a capacidade de originar variantes não-mucóides em 
resposta às condições de stress testadas. A infeção de G. mellonella com as estirpes mucóides 
e respetivas variantes não-mucóides revelou que algumas destas variantes apresentaram uma 
virulência atenuada relativamente aos respetivos isolados mucosos, enquanto outras 
mantiveram um grau de virulência semelhante. 
Do ponto de vista da caracterização fenotípica compararam-se células mucóides com as 
variantes não-mucóides obtidas a partir da incubação com limitação de nutrientes de quatro 
estirpes pertencentes a três espécies do complexo Bcc. A comparação englobou a motilidade 
“swimming” e “swarming”, a formação de biofilmes e a produção de sideróforos. Avaliou-se 
também a suscetibilidade ao detergente SDS e compararam-se os padrões de LPS, para 
estudar possíveis alterações membranares. Foi ainda estudada a resistência a agentes 
causadores de stress oxidativo (hidroperóxido de cumeno e peróxido de hidrogénio) e a 
antimicrobianos das famílias dos beta-lactâmicos (piperacilina/tazobactam, ceftazidima, 
imipenemo, aztreonam), aminoglicósidos (amicacina) e quinolonas (ciprofloxacina). No geral 
a motilidade “swimming” e a formação de biofilmes apresentou-se sempre alterada entre as 
células mucóides e não-mucóides apesar de não ser possível estabelecer nenhuma tendência. 
Por outro lado, algumas variantes não-mucóides apresentaram uma maior produção de 
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sideróforos e maior suscetibilidade aos antibióticos quando comparadas com as células 
mucóides.  
Com o objetivo de identificar os possíveis mecanismos que conduzem à variação de 
morfotipo, analisou-se a expressão génica de células mucóides e não-mucóides da estirpe B. 
multivorans ATCC17616 através de uma experiência de microarrays onde foram comparados 
os respetivos transcritos. Os resultados mostraram uma diminuição da expressão de genes 
codificantes de proteínas do sistema de secreção de tipo VI nas variantes não-mucóides, o que 
pode estar relacionado com uma diminuição da virulência. Os genes codificantes de proteínas 
constituintes das fimbrias estavam também sub-expressos nas células não-mucóides, enquanto 
os genes codificantes de proteínas envolvidas na síntese flagelar e na quimiotaxia tinham a 
sua expressão aumentada. Estes resultados estão em concordância com o aumento da 
motilidade “swimming” e a diminuição da formação de biofilmes observadas nas células não-
mucóides da estirpe B. multivorans ATCC17616. 
No conjunto de dados de expressão génica observaram-se também alterações na 
expressão de genes codificantes de vários reguladores de transcrição e de proteínas envolvidas 
na transdução de sinal. Entre os possíveis reguladores de transcrição inclui-se o gene 
Bmul_2557 que codifica uma proteína da família LysR. Pensa-se que esta família de 
reguladores possa estar envolvida em processos celulares como a resistência a antibióticos e a 
síntese de fatores de virulência. Iniciou-se então uma estratégia de clonagem para eliminar 
esse gene do genoma da estirpe B. multivorans ATCC17616. Esta estratégia consistiu na 
amplificação das regiões a montante e a jusante do gene e na sua introdução num vector de 
clonagem não replicativo para Burkholderia, juntamente com uma cassete que confere 
resistência a trimetoprim, a qual irá substituir o gene-alvo após dupla recombinação do 
plasmídeo com o genoma. A obtenção deste mutante é crucial para entender o papel deste 
regulador de Burkholderia na conversão de células mucóides em não-mucóides. 
Em conclusão, a variação de morfotipo em espécies do complexo Bcc poderá estar 
relacionada com alterações fenotípicas e de expressão génica que parecem ser induzidas por 
exposição das células mucóides a diferentes stresses. A variação de morfotipo é um fenómeno 
relevante no decorrer das infeções crónicas com bactérias do complexo Bcc em doentes com 
fibrose quística e a compreensão dos possíveis mecanismos celulares por detrás deste 
processo representa uma área-chave para estudos futuros. 
 
Palavras-Chave: Burkholderia, Exopolissacárido, Variação de morfotipo, Condições de 
stress, Virulência, Fibrose quística.  
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Abstract 
 
 
The genus Burkholderia comprises a group of metabolically diverse gram-negative β-
proteobacteria that can colonize a wide variety of environments including soil, water, plants, 
animals and humans. Particularly, bacteria from Burkholderia cepacia complex (Bcc) are 
well-known opportunistic pathogens infecting cystic fibrosis (CF) and immunocompromised 
patients. Since CF is caused by mutations in a gene encoding a chloride channel, thus 
affecting mucus clearance in lungs, infection with antibiotic multi-resistant Bcc bacteria can 
lead to chronic lung inflammation and in some cases septicemia. Bcc pathogenicity is related 
to several virulence factors, including the exopolysaccharide (EPS) cepacian which is also a 
common feature within the genus Burkholderia conferring these bacteria a mucoid phenotype. 
Mucoid-to-nonmucoid conversion occurs in Bcc long-term infections of CF patients’ airways 
and it is thought to be highly important in bacterial virulence and adaptation. 
This study assessed mucoid-to-nonmucoid morphotype variation of different 
Burkholderia species upon nutrient starvation and ciprofloxacin treatment. It was shown that 
clinical and environmental Bcc and non-Bcc mucoid strains could originate nonmucoid 
variants in response to the stress conditions tested. Several of these nonmucoid variants had 
an attenuated virulence in Galleria mellonella model of infection, while others remained 
similar to the mucoid parental strains. Phenotypic characterization of mucoid isolates and 
nonmucoid variants obtained under nutrient starvation was performed. In general, swimming 
motility and biofilm formation did always differ between mucoid and nonmucoid cells 
although no tendency was established. On the other hand, some nonmucoid variants showed 
higher siderophore production and antibiotic susceptibility when compared to the mucoid 
isolates. 
Also, mucoid and nonmucoid cells evidenced differences in their gene expression 
profile, as microarray analysis revealed the altered expression of genes encoding type VI 
secretion system proteins, fimbrial proteins and proteins involved in flagellar biosynthesis and 
chemotaxis. Understanding morphotype variation signals and mechanisms represents a key 
area for future studies. 
 
 
Keywords: Burkholderia, Exopolysaccharide, Morphotype variation, Stress conditions, 
Virulence, Cystic fibrosis.  
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1. Introduction 
 
1.1  Burkholderia genus 
 
1.1.1  Diversity 
Burkholderia genus is a metabolically and genetically diverse group of gram-negative 
β-proteobacteria that can be found in water, soil, in association with plants or as pathogens in 
animals and humans (1, 2). The first isolates of this group were primarily described by 
William Burkholder in 1950 who classified them as Pseudomonas cepacia (3). Molecular 
taxonomic analysis led to the transfer of these bacteria to a new genus distinct from 
Pseudomonas, called Burkholderia. Despite the creation of this new genus, heterogeneity was 
still very high among these bacteria and their correct identification was very difficult. The 
classification of the bacteria from Burkholderia genus has changed during the past two 
decades as new members have been identified. A group of phenotypically similar bacteria 
were initially clustered in different genomovars that were later identified as new genetic 
species and the collective of these species was named “Burkholderia cepacia complex (Bcc)” 
(1, 4). Initially, Bcc comprised ten formally named species, classified based on phenotypic 
and genotypic analyses: Burkholderia cepacia, Burkholderia multivorans, Burkholderia 
cenocepacia, Burkholderia stabilis, Burkholderia vietnamiensis, Burkholderia dolosa, 
Burkholderia ambifaria, Burkholderia anthina, Burkholderia pyrrocinia and Burkholderia 
ubonensis. A new polyphasic approach based on sequence analysis of the recA gene, 
multilocus sequence typing (MLST) studies and phylogenetic comparison of the full-length 
16S rRNA gene sequence have allowed the proposal of seven additional species: 
Burkholderia latens, Burkholderia diffusa, Burkholderia arboris, Burkholderia seminalis, 
Burkholderia metallica, Burkholderia contaminans and Burkholderia sabiae (1, 5). All Bcc 
species have high sequence similarity in some particular genes, including 98-100 % in the 
16S rRNA gene, 94-95 % in recA gene, and 30-50 % of DNA-DNA hybridization (6). 
 
1.1.2  Pathogenesis 
The first identified Burkholderia species were related to some particular plant disease 
and consequently they were originally known as plant pathogens. However not all the 
relations between Burkholderia species and plants are pathogenic. Some species can develop 
symbiotic interactions, for example by fixing atmospheric nitrogen, as B. vietnamiensis, 
Introduction 
2 
 
Burkholderia kururiensis, Burkholderia xenovorans, Burkholderia silvatlantica and 
Burkholderia phymatum, allowing them to colonize the plant roots, stems and leaves (4). 
As mentioned above, Burkholderia species are highly versatile and are able to colonize 
very different ecological niches. Nowadays a wide number of Burkholderia species is known 
as being capable of infecting humans and animals. Two of the first identified species are 
Burkholderia mallei, which causes glanders in horses, mules and donkeys, and Burkholderia 
pseudomallei, responsible for melioidosis in humans and animals (7, 8). Over the years, other 
Burkholderia species, including all the Bcc species, were isolated from both the environment 
and human clinical sources (reviewed in (4)). 
According to Centers for Disease Control and Prevention in the USA, Bcc species poses 
little medical risk to healthy people (9), although one particular situation is the B. cepacia 
cutaneous foot infections found in military personnel during swamp training, a lesion called 
“swamp foot” (10). In the other hand, these bacteria can cause severe infections in immuno-
compromised patients or in patients with chronic lung diseases like cystic fibrosis (CF). 
CF, also known as mucoviscidosis, is an autosomal recessive disorder that affects lungs 
and digestive system of about 70000 people worldwide (11). CF is caused by mutations in the 
gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR), a chloride 
channel (12). CF is characterized by the abnormal function of exocrine glands leading to the 
production of unusually thick and sticky mucus. In the lungs this condition is responsible for 
the clogging of the airways manifested by wheezing and air trapping. The high mucus 
production and decreased mucus clearance may result in chronic cough and frequent 
colonization with typical CF pathogens like Staphylococcus aureus, Haemophilus influenzae, 
mucoid and nonmucoid Pseudomonas aeruginosa, and Bcc species (13, 14). 
Patients infected with Bcc bacteria show a wide variety of symptoms, ranging from 
chronic infection that does not alter lung function to serious respiratory infections with rapid 
deterioration of lung function, bacteremia and death. This most severe condition is known as 
“cepacia syndrome” and occurs mostly in patients with CF (9, 15). Besides severe infection, a 
problematic issue of Bcc bacteria is their capability to be transmitted among people by social 
contact. This resulted in the application of strict guidelines to avoid any contact between Bcc-
infected people and CF patients not infected with Bcc (5). However, as these rules took some 
time to implement, some reports notified the isolation of Bcc strains from CF patients in 
multiple countries (16, 17). Different patients infected with the same strain may have a wide 
range of symptoms, which makes the diagnosis and treatment difficult. Moreover, if the 
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infection is chronic, some Bcc species become highly resistant to antibiotics probably due to 
mutation or horizontal gene transfer (18). 
Different Bcc species have the capability to cause infections and some of them have 
been identified in several CF patients around the world (table 1). B. cenocepacia and B. 
multivorans are the most predominant species among these patients representing around 90 % 
of all Bcc infections in the world. In Portugal, the most common species are B. cenocepacia 
and B. cepacia, having also been identified B. stabilis and B. multivorans. These observations 
made B. cenocepacia, B. multivorans and B. cepacia the most studied species among all 
Burkholderia species (19, 20).  
 
Table 1 - Distribution of Bcc species in selected populations of CF patients (from (19)). 
 
 
1.2  Virulence Factors in Bcc 
 
Although Bcc bacteria have only been identified in 3.5 % of CF patients, their presence 
contributes to the decline of lung function leading to a more severe health condition (21). For 
this reason, intensive research has been made to elucidate the mechanisms of infection, host-
pathogen interaction and virulence factors involved in Bcc colonization. It is now known that 
Bcc bacteria share some colonization strategies with other mucosal pathogens, having 
virulence factors encoding genes clustered in different regions of their genomes. Some of 
these virulence factors include lipopolysaccharide (LPS), exopolysaccharide (EPS), flagella, 
cable pili, adhesins, lipases, proteases and siderophores (21–25). These elements can be 
involved in different phases of the infection process, like attachment and invasion of the host 
cell, bacterial intracellular adaptation and survival, acquisition of iron and virulence 
regulation. The study of each of these virulence factors stimulates the development of new 
therapeutic strategies that would allow the control and treatment of Bcc infections. Besides, 
advances in this field would also help to prevent the spread of Bcc infections, mainly among 
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CF patients, through the creation of new vaccines. Currently some studies are testing different 
constituents of the LPS of Burkholderia clinical isolates as potential candidates for synthetic 
neoglycoconjugate vaccines (26, 27). 
 
1.2.1  Exopolysaccharide (EPS) 
EPS is a virulence factor commonly produced by most of the Burkholderia species. 
They can produce several types of EPS with different structures and properties, alone or in 
mixtures. The most common EPS is called cepacian and some studies evidenced its 
production by Bcc and non-Bcc species both from clinical and environmental sources. For this 
reason it was considered as “the EPS characteristic of the Bcc” (28, 29). 
Cepacian biosynthesis is assigned to two clusters of genes, bce-I and bce-II (29, 30) and 
it is structurally characterized by a heptasacharide repeat-unit backbone, three short lateral 
chains and 1 to 3 acetyl groups that help bacteria to control EPS properties. The backbone is 
composed by units of D-glucose, D-rhamnose, D-mannose, D-galactose and D-glucuronic 
acid in the molar ratio of 1:1:1:3:1 and linked by (1→3) glycosidic bonds (28, 31). 
The particular type and amount of EPS that is produced by each Burkholderia strain is 
probably related to the environment in which that strain usually lives or to the conditions 
present during its growth, possibly helping to improve its niche adaptation. 
 
1.2.1.1  Role of EPS in virulence 
EPS is an important virulence factor whose functions vary with the producing 
microorganism and its ecological niche. Sometimes the capacity and rate of production of 
these polymers are related to the pathogenicity of the organism. Their functions include 
protection and improvement of bacteria condition in order to better adapt to different 
environments (32). Bacteria living in soil are often exposed to adverse conditions as the lack 
or excess of water. EPS hydrophilicity possibly contributes to retain water through the 
creation of a hydrated layer that acts as a cellular buffer against rapid changes in soil water 
content. This function helps to protect against desiccation of the cells, predation by 
protozoans and molecular uptake of toxic compounds to the cell (32, 33). Moreover, due to its 
negative charge EPS can also aid soil bacteria to sequester positive ions in nutrient poor 
environments. 
Inside the hosts, polysaccharides are most related to the overcoming of the immune 
defenses (34, 35). Inside the lungs, macrophages and neutrophils are two very important types 
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of phagocytic cells that constitute one of the first lines of defense against foreign bodies. In 
2004, Conway and co-workers showed that EPS leads to an approximately 3-fold decrease in 
the interaction of B. cenocepacia cell surface with macrophages and neutrophils. This 
suggests that bacterial surface structures are masked by EPS and can no longer be recognized 
by these phagocytic cells (36). Moreover, neutrophils do also act by producing reactive 
oxygen species (ROS) that constitute a powerful antibacterial agent. It is known that B. 
cenocepacia EPS has the ability to scavenge ROS, which can strongly interfere with the 
function of immune cells (37). Another ability of the EPS is to interact with antimicrobial 
peptides (AMPs) produced by the host immune system. AMPs can change their 
tridimensional conformation near the bacterial membrane leading to its permeabilization and 
consequent death of the microorganism. The interaction between EPS and AMPs induces a 
change in the conformation of AMPs resulting in a decrease of its antimicrobial activity (34). 
One common property of Bcc infections is the formation of a biofilm layer, whose 
skeleton is mainly composed of EPS, proteins and DNA. These biofilms physically protect 
the cells against dangerous chemical agents and contributes to the establishment of a chronic 
lung infection. It has been shown that Burkholderia mutants unable to produce cepacian form 
less biofilm than the wild-type producing strains (38). 
 
1.3  Mucoid-to-nonmucoid morphotype variation 
 
Morphotype variation is a relatively common process during the adaptation of an 
organism to its environment and can be linked to genetic or epigenetic changes. For some 
pathogens this switch is related to their virulence, influencing the invasion of mucosal 
barriers, adherence to the tissues and immune evasion (39). 
Many studies have been focused on P. aeruginosa, one of the most important and well-
known colonizers of CF patients lungs. Usually, the initial colonizers are nonmucoid P. 
aeruginosa strains which start to produce alginate (EPS) during the course of infection. The 
alginate-containing matrix is associated to a considerable decline in pulmonary function of CF 
patients, resulting in a significant increase in morbidity and mortality (40). 
Relatively to Bcc, morphotype switch was also identified during the CF patients’ lung 
infection period. In opposition to P. aeruginosa, Bcc infections usually initiate with mucoid 
strains. Zlosnik and co-workers have studied the prevalence of mucoid and nonmucoid Bcc 
strains during 26 years of Bcc infection in 100 CF patients. Thirteen cases have occurred in 
which mucoid-to-nonmucoid conversions were observed in infections with B. multivorans, B. 
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cenocepacia and B. vietnamiensis. In contrast, only two nonmucoid-to-mucoid conversions 
occurred in B. cenocepacia and B. vietnamiensis. Interestingly, B. cenocepacia, the most 
virulent specie of the Bcc, has an unusually high frequency of nonmucoid isolates (41), 
suggesting that the nonmucoid isolates are more prone to virulence while the mucoid ones to 
persistent colonization. It was later shown that the decline of lung function was proportional 
to nonmucoid/mucoid Bcc ratio. Patients infected only with nonmucoid strains had a more 
rapid decline of lung function than those colonized exclusively with mucoid bacteria (42). 
 
1.4  Objective 
 
Morphotype variation during bacterial colonization of hosts is highly important in 
virulence and adaptation. Previous work have evidenced differences at transcriptomic and 
phenotypic level between clonal isolates of B. multivorans D2095 (mucoid) and D2214 
(nonmucoid), sequentially isolated from a CF patient. Besides EPS production, the main 
differences were related to motility, biofilm formation and virulence (43). Further work have 
shown that B. multivorans D2095 could originate nonmucoid variants when exposed to 
several laboratory stress conditions such as nutrient starvation, osmotic and oxidative stress 
agents, antimicrobials and temperatures above and below the optimal for growth, among 
others (44). Similarly, mucoid B. cenocepacia C3921 and B. multivorans C5568 isolated from 
CF patients showed conversion from mucoid to nonmucoid phenotype after being exposed to 
antibiotics such as ciprofloxacin and ceftazidime (42). 
The question if other Bcc and non-Bcc species, besides B. multivorans, were also 
capable of mucoid-to-nonmucoid conversion when exposed to laboratory stress conditions 
was raised. Therefore, the main goal of this work was to test mucoid-to-nonmucoid variation 
of different Burkholderia species upon nutrient starvation and in the presence of the 
antimicrobial ciprofloxacin and to characterize some of the obtained mucoid/nonmucoid pairs 
regarding the phenotypic traits, expression profile and virulence. 
A second part of this work was focused on the molecular aspects of EPS production 
regulation. Microarray data have shown some transcriptional regulators that were under-
expressed in B. multivorans ATCC17616 nonmucoid variant, in comparison with the 
respective mucoid wild-type. One of those genes was Bmul_2557, a LysR family 
transcriptional regulator. In this work a deletion mutant for this gene started to be constructed 
in order to study its influence on EPS production regulation and morphotype variation. 
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2.  Materials and Methods 
 
The composition of the culture media, solutions and buffers used in this work is specified in 
the Annex I A. and B. 
 
Bacterial strains, plasmids and culture conditions. The bacterial strains and plasmids used 
in this study are described in Table 2. E. coli was grown at 37ºC in LB broth, supplemented 
with kanamycin (50 µg/ml), chloramphenicol (50 µg/ml) or trimethoprim (80 µg/ml) when 
necessary. Burkholderia strains were grown in LB, in Pseudomonas isolation agar (PIA), in 
exopolysaccharide producing medium S/SM, in MM or in YEM at 30ºC (for non-Bcc strains) 
or 37°C (for Bcc strains). 
 
DNA manipulation techniques. Genomic and plasmid DNA extraction and purification, 
DNA restriction analysis and DNA amplification by PCR were performed using standard 
protocols (45). Nucleotide sequence determination was obtained as a paid service (Eurofins, 
Germany). E. coli transformation was done by electroporation using standard procedures (45). 
 
Bacterial genotyping. Genomic DNA preparation and pulsed-field gel electrophoresis 
(PFGE) were performed as previously described (46). Prior to PFGE, immobilized DNA was 
digested with 20 U of SpeI restriction endonuclease before being loaded into a 1 % (w/v) 
agarose gel in TBE buffer. PFGE was carried out with a Gene Navigator apparatus 
(Pharmacia-LKB, Sweden) at 200 V using 5-120 seconds pulse times for 22 h. 
 
Mutant construction. The 1791bp HindIII/XbaI upstream region (L) of Bmul_2557 gene 
was amplified by PCR from B. multivorans ATCC17616 genomic DNA using the primers 
Bmul2557L-low (5’-GAATCTAGACATGGTCTGAATCTGG-3’; restriction site underlined) 
and Bmul2557L-up (5’-CCTAAGCTTGCTTCGAGATATGGC-3’). After digestion with the 
appropriate restriction endonucleases, the fragment was cloned into pBCKS- vector giving 
rise to pAT312. The 1800 bp XbaI/SacI downstream region (R) of Bmul_2557 was amplified 
using the primers Bmul2557R-low (5’-AGCGAGCTCGTTCGAGCATCGGC TT-3’) and 
Bmul2557R-up (5’-GACTCTAGACCGGGCCTGCAGTAAA-3’) and cloned into pDrive 
vector, resulting in the plasmid pAT712. This XbaI/SacI fragment was then cloned into the 
same restriction sites of pAT312 and the resulting plasmid was named pAT812. A fragment 
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containing the trimethoprim resistance cassette from pUC-TP was then cloned into the XbaI 
site of pAT812 originating pAT812-Tp. To delete the gene Bmul_2557 from B. multivorans 
ATCC17616, pAT812-Tp will be introduced into the mucoid isolate by electrotransformation. 
The recombinant colonies will be first selected in the presence of trimethoprim. To identify 
the ones that will have lost the vector a medium supplemented with chloramphenicol will be 
used. Gene deletion will be confirmed by PCR amplification followed by DNA sequence 
determination. 
 
Table 2 – Strains and plasmids used in this study. 
Strain / Plasmid Relevant characteristic(s) Source/Reference
Strains   
B. multivorans D2095 Cystic fibrosis clinical isolate, Canada (43) 
B. multivorans ATCC17616 Soil isolate, USA (47) 
B. cepacia IST408 Cystic fibrosis clinical isolate, Portugal (48) 
B. cepacia ATCC17759 Soil isolate, Trinidad (49) 
B. cenocepacia J415 Cystic fibrosis clinical isolate, UK (50) 
B. stabilis LMG14086 Respirator, UK (51) 
B. stabilis LMG18888 Human blood, Belgium (52) 
B. vietnamiensis PC259 Cystic fibrosis clinical isolate, USA (53) 
B. ambifaria AMMD Root-colonizing bacterium, USA (54) 
B. ambifaria CEP0958 Cystic fibrosis clinical isolate, Australia (54) 
B. dolosa CEP0743 Cystic fibrosis clinical isolate, Canada D. P. Speert 
B. anthina J2552 Soil isolate, UK (55) 
B. anthina FC0974 Cystic fibrosis clinical isolate, Canada D. P. Speert 
B. anthina FC0967 Cystic fibrosis clinical isolate, Canada D. P. Speert 
B. phymatum STM815 Soil isolate, French Guiana; nitrogen fixation (56) 
B. xenovorans LB400 Soil isolate, USA; degradation of polychlorinated 
biphenyl compounds 
(57) 
B. cenocepacia J2315 Cystic fibrosis clinical isolate, UK (58) 
Escherichia coli DH5α recA1, lacUi69, o80dlacZ ∆M15 Gibco BRL 
   
Plasmids   
pBCKS- 3.4-kb phagemid derived from pUC19; lac promoter; Cmr Stratagene 
pDrive 3.85-kb vector; lacZ α-peptide; Ampr Kmr Qiagen 
pUC-Tp pUC-GM derivative with a 1.1-kb Tpr gene cassette. Tpr, 
Ampr 
(59) 
pAT312 pBCKS derivative carrying the upstream region of 
Bmul_2557 gene 
This study 
pAT712 pDrive derivative carrying the downstream region of 
Bmul_2557 gene 
This study 
pAT812 pAT312 derivative carrying the downstream region of 
Bmul_2557 gene 
This study 
pAT812-Tp pAT812 derivative carrying a Tpr cassette between the 
upstream and downstream region of Bmul_2557 gene 
This study 
Cm, Chloramphenicol ; Amp, Ampicillin ; Km, Kanamycin ; Tp, Trimethoprim  
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Isolation and processing of RNA samples. For RNA analysis mucoid and nonmucoid B. 
multivorans ATCC17616 cells were resuspended in RNAprotect bacteria reagent, and total 
RNA extraction was carried out using RNeasy MiniKit (Qiagen), following the manufactures’ 
recommendations. The integrity of RNA was confirmed on an Agilent 2100 Bioanalyser 
using an RNA Nano assay. Biological triplicates of RNA from each bacterial culture were 
processed and analysed for use on Affymetrix custom dual-species Burkholderia arrays, 
according to the manufacturer’s Prokaryotic Target Preparation Assay, as previously 
described (43).  
 
Microarray data analysis and validation. Scanned arrays were analysed with Affymetrix 
Expression Console software to assure that all quality parameters were in the recommended 
range. Subsequent analysis was carried out with DNA-Chip Analyser 2010. The first step was 
the application of a digital mask, leaving for analysis only the 9291 probe sets representing B. 
multivorans ATCC17616 transcripts. The arrays were then normalized to a baseline array 
with median CEL intensity by applying an Invariant Set Normalization Method (60). 
Triplicates for each bacterial isolate were weighted gene-wise by using inverse squared 
standard error as weights. All genes compared were considered to be differentially expressed 
if the 90 % lower confidence bound of the fold change (LCB) between experiment and 
baseline was above 1.3. Validation of microarrays expression data was performed by qRT-
PCR as previously described (29). The primer sequences used are shown in Annex II Table 
A1. ProC and TrpB were used as housekeeping genes. Relative quantification of gene 
expression by qRT-PCR was determined using the ∆∆Ct method (61). 
 
Switching of colony morphology upon stress exposure. Mucoid-to-nonmucoid conversion 
was evaluated upon nutrient starvation and in the presence of the antimicrobial ciprofloxacin 
(Cip). Triplicates of each Burkholderia strain were grown in test tubes with 3 ml of liquid SM 
medium (inoculated to final OD640nm of 0.1). To test nutrient starvation, the cultures were 
maintained statically at 37°C (Bcc strains) or 30ºC (non-Bcc strains) for 21 days. Aliquots 
were removed at 0, 7, 14, and 21 days, spread plated onto YEM agar, and incubated at 37°C 
or 30ºC for 2 days. To test Cip stress, concentrations above the MIC (table 3) were added to 
the medium and incubated for 7 days, at 37ºC (Bcc strains) or 30ºC (non-Bcc strains) with no 
agitation. After 7 days the cultures were vortexed, spread plated onto YEM agar and 
incubated at 37°C or 30ºC for 2 days. In both laboratory conditions plates were examined 
with respect to the total number of bacteria and to the proportion of the mucoid and the 
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nonmucoid phenotypes. Colonies showing nonmucoid appearance were picked to MM solid 
medium and incubated at 37ºC or 30ºC for 2 days. After a second passage, exopolysaccharide 
production in MM liquid medium and PFGE genotyping of two representative nonmucoid 
colonies were performed. 
 
Long-term nutrient starvation. Bacterial cells grown overnight in LB liquid medium were 
harvested, washed twice in NaCl 0,9 % (w/v) and inoculated in duplicate in 50 ml of M63 
minimal medium without carbon source to an OD640 of 1.0. Cultures were grown for 28 days 
at 37ºC and 250 rpm orbital agitation. Samples were diluted and plated at 0, 15 and 28 days in 
MM solid medium, colony forming units (CFUs) were quantified and percentages of survival 
were determined. 
 
Phenotypic assays. (i) Exopolysaccharide quantification: The amount of EPS was assessed 
based on the dry weight of the ethanol-precipitated polysaccharide recovered from triplicates 
of 100 ml culture samples (supplemented with NaCl (0.1 % w/v)) of the different strains 
grown in liquid MM medium over 6 days at 30°C with orbital agitation as previously 
described (38). (ii) Antimicrobial susceptibility: The resistance of mucoid and nonmucoid Bcc 
strains to antimicrobials of different classes was compared using the agar disc diffusion 
method (62). Bacterial cultures grown in MM liquid medium for 10.5 h at 37ºC with agitation 
were diluted to an OD640 of 0.1 and 100 µl of each culture were inoculated in Mueller-Hinton 
(Difco-Laboratories) agar plates. Antibiotic discs of amikacin (30 µg), piperacillin (75 µg) 
plus tazobactam (10 µg), aztreonam (30 µg), ciprofloxacin (5 µg), imipenem (10 µg) and 
ceftazidime (30 µg) (BD Sensidisc) were applied onto each plate and growth inhibition 
diameters were measured after 24 h of incubation at 37ºC. (iii) Zone inhibition assays: 
Bacterial cultures grown in MM liquid medium for 10.5 h at 37ºC with agitation were diluted 
to an OD640 of 0.1 and 100 µl of each culture were spread onto LB agar plates. Sterile 6mm- 
diameter paper discs were placed on the agar surface and were loaded with 10 µl of cumene 
hydroperoxide (10 % v/v), H2O2 (0.3 %; 3 % and 30 % v/v) and SDS (10 % w/v). Plates were 
incubated at 37ºC and the growth inhibition halos were measured after 24 h. (iv) Siderophores 
production: Siderophores production of mucoid and nonmucoid Bcc strains was determined 
by modified Chrome azurol S (CAS) agar diffusion assay (63). CAS agar plates were used, in 
which CAS solution was mixed with 900 ml MM solid medium. Bacterial cultures grown as 
previously described were diluted to an OD640 of 1 and 5 µl spots were inoculated onto CAS-
MM agar plates. Plates were incubated at 37ºC and siderophore production yellow halos were 
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measured after 24 h and 48 h. (v) Bacterial hydrophobicity: The cell surface hydrophobicity 
was determined by measuring the bacterial adhesion to n-hexadecan, based on the BATH 
method proposed by Rosenberg and co-workers (64). Bacterial cultures were inoculated in 
MM liquid medium and grown overnight at 37ºC and 250 rpm orbital agitation. Cultures were 
harvested by centrifugation, washed twice with phosphate-buffered saline (PBS) and 
resuspended in 1.5 mL of PBS to a final OD640 of 0.6. Cell suspensions were mixed with 500 
µl of n-hexadecan in test tubes, vigorously vortexed for 20 s and immobilized for 30 min to 
allow phases to separate. Aqueous phase DO640 was measured and the percentage of 
hydrophobicity was determined using the formula (%) = (1 - OD640 aqueous phase / OD640 
initial cell suspension) x 100. (vi) Biofilm formation: Biofilm formation assays were 
performed as previously described (38). Overnight bacterial cultures were used to inoculate S 
liquid medium with an OD640 of 0.05 and 150 µL of these cell suspensions were inoculated 
into wells of a 96-well polystyrene microtiter plate (Greiner Bio-one). Plates were incubated 
for 24 h and 48 h at 37ºC without agitation. For biofilm quantification, unattached bacteria 
were removed by washing the wells three times with NaCl 0.9 % (w/v). Adherent cells were 
stained with 150 µL of 1 % (w/v) crystal violet solution for 15 min at room temperature, 
followed by three NaCl 0.9 % (w/v) washes. The stained biofilm cells were resuspended in 
150 µL of 96 % ethanol and OD590 was measured using a VERSAmax tunable microplate 
reader (Molecular Devices). (vii) Motility assays: Swimming and swarming plates were 
prepared as described in Annex I A. For estimation of motility, bacterial cultures grown as 
previously described were directly inoculated onto agar surface and plates were incubated at 
37ºC. The diameter of the halos was measured after 24 h and 48 h. (viii) LPS analysis: LPS 
was obtained by microextraction using Proteinase K digestion, as previously described (65). 
Briefly, bacterial cells corresponding to an OD640 of 0.7 in 1.5 mL were harvested by 
centrifugation at 14000 g for 5 min and washed with PBS. The pellet was solubilized in 50 µl 
of lysis buffer. Bacterial proteins were digested by 1 h incubation at 60ºC with 10 µL of 
proteinase K digestion buffer. 10 µl of LPS fractions were analysed by SDS–polyacrylamide 
gel electrophoresis on a 15 % (w/v) gel (45). The electrophoresis was run at 12 mA while the 
samples were in the stacking gel and then at 15 mA when they reached the resolving gel. The 
LPS pattern was revealed by silver nitrate staining. The gel was fixed overnight in 150 ml of 
fixing reagent and it was then oxidised for 5 min in oxidising reagent. The gel was washed 8 
times for 30 min with distilled water, stained for 10 min with 120 ml of staining solution and 
followed by another three 10-min washes with distilled water. The stain was developed with 
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the addition of 150 ml of developing solution for approximately 10 min. The gel was quickly 
transferred to stopping solution for 3 min and washed twice with distilled water. 
 
Virulence determination in Galleria mellonella. Killing assays were performed as 
previously described (66). Larvae were injected with a number of CFUs varying between 
1x104 and 7x107 diluted in 10 mM MgSO4 with 1.2 mg/ml ampicillin and the survival rate 
evaluated for 7 days post-infection. As a negative control, 10 mM MgSO4 with 1.2 mg/ml 
ampicillin was used. Triplicates of ten larvae were used in each experiment. 
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3.  Results 
 
3.1  Morphotype variation triggered by nutrient starvation and ciprofloxacin 
Morphotype variation upon nutrient starvation and in the presence of ciprofloxacin was 
studied for a total of 16 Burkholderia strains (tables 2 and 3). These strains include 9 Bcc 
isolates from clinical source (B. multivorans D2095; B. cepacia IST408; B. cenocepacia J415; 
B. stabilis LMG18888; B. vietnamiensis PC259; B. ambifaria CEP0958; B. dolosa CEP0743; 
and B. anthina FC0974 and FC0967), 5 Bcc environmental isolates (B. multivorans 
ATCC17616; B. cepacia ATCC 17759; B. stabilis LMG14086; B. ambifaria AMMD; and B. 
anthina J2552) and 2 non-Bcc environmental isolates (B. phymatum STM815 and B. 
xenovorans LB400). Each isolate was submitted to nutrient starvation for 21 days or to 
inhibitory concentrations of ciprofloxacin (table 3) for 7 days and the percentage of mucoid-
to-nonmucoid conversion was calculated. Eleven of the 16 tested strains have shown 
morphotype variation upon one or both stresses (fig. 1). 
 
Table 3 – Ciprofloxacin concentration used to induce morphotype variation in Burkholderia and amount of 
EPS being produced. 
Strain 
Ciprofloxacin MIC 
(µg/mL) 
Exposure [ciprofloxacin] 
(µg/mL) 
EPS production 
(g/L) 
B. multivorans D2095 4 12.5 3.7 ± 0.1 
B. multivorans ATCC 17616 1 3 0.3 ± 0.1 
B. cepacia IST408 1 12.5 1.2 ± 0.5 
B. cepacia ATCC 17759 1 12.5 ND 
B. cenocepacia J415 2 12.5 ND 
B. stabilis LMG14086 1 2 ND 
B. stabilis LMG18888 1 12.5 0.2 ± 0.1 
B. vietnamiensis PC259 1 12.5 5.7 ± 0.3 
B. ambifaria AMMD 1 2 ND 
B. ambifaria CEP0958 1 6 3.9± 0.3 
B. dolosa CEP0743 2 12.5 1.2 ± 0.4 
B. anthina J2552 1 12.5 ND 
B. anthina FC0974 1 2 0.4 ± 0.2 
B. anthina FC0967 2 3 1.6 ± 0.6 
B. phymatum STM815 8* 3 1.9 ± 0.2 
B. xenovorans LB400 8* 3 5.2 ± 0.2 
MIC, Minimum inhibitory concentration; ND, not determined; *MIC determined at 30ºC. 
 
Nutrient starvation induced mucoid-to-nonmucoid variation in the two non-Bcc strains, 
B. phymatum STM815 and B. xenovorans LB400 and in both the clinical and environmental 
Bcc strains B. cepacia IST408, B. multivorans ATCC17616 and D2095, B. vietnamiensis 
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PC259, B. dolosa CEP0743, and B. anthina FC0974 and FC0967. The percentages of 
morphotype alteration varied from 1 % to 16 %. In the presence of ciprofloxacin only 4 Bcc 
clinical isolates originated nonmucoid colonies (B. multivorans D2095, B. stabilis 
LMG18888, B. ambifaria CEP0958 and B. anthina FC0974), with percentages of conversion 
between 0.2 % and 4 %. 
 
  
Figure 1 – Morphotype variation in 16 Burkholderia isolates from clinical (bold) and environmental (not 
bold) source: B. cepacia ATCC 17759, B. cepacia IST408, B. multivorans ATCC 17616 and D2095, B. 
cenocepacia J415, B. stabilis LMG14086, B. stabilis LMG18888, B. vietnamiensis PC259, B. dolosa 
CEP0743, B. ambifaria AMMD and CEP0958, B. anthina J2552, FC0967 and FC0974, B. phymatum 
STM815 and B. xenovorans LB400. The percentage of mucoid-to-nonmucoid conversion was determined 
after 21 days of nutrient starvation ( ) or after 7 days in the presence of ciprofloxacin ( ). 
 
All the nonmucoid variants that were obtained and the respective mucoid wild-type 
strains were tested for EPS production. EPS quantification was performed after a 6-day 
growth in MM liquid medium (table 3). It was observed that the nonmucoid variants produced 
none or only trace amounts of EPS in comparison with the wild-type strains. 
 
 
Figure 2 – PFGE profiles of SpeI-digested genomic DNA of the mucoid parental isolates (P) and the 
nonmucoid variants (V) obtained under nutrient starvation or in the presence of ciprofloxacin of: B. cepacia 
IST408 (1); B. multivorans ATCC 17616 (2) and D2095 (3); B. stabilis LMG18888 (4); B. vietnamiensis 
PC259 (5); B. dolosa CEP0743 (6); B. ambifaria CEP0958 (7); B. anthina FC0974 (8) and FC0967 (9); B. 
phymatum STM815 (10); and B. xenovorans LB400 (11). Arrowheads indicate differences in banding 
patterns. 
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To confirm the clonality between the nonmucoid variants and the respective mucoid 
wild-types, PFGE was performed. SpeI-restricted profiles were similar in the majority of 
mucoid/nonmucoid pairs, with the exception of the variants of B. cepacia IST408, B. stabilis 
LMG18888 and B. anthina FC0967 which evidenced some genomic re-arrangements (fig. 2). 
Stability tests showed that all the nonmucoid variants obtained under both stresses were 
stable. After a 7-days incubation in MM liquid medium the cultures were plated in MM solid 
medium and no recurrence of the mucoid morphotype was observed after 48 h.  
 
3.2  Survival under nutrient starvation 
To evaluate if mucoid and nonmucoid cells have different abilities to survive to 
starvation, each mucoid isolate and the respective nonmucoid variant obtained under nutrient 
limitation were grown in minimal medium without carbon source for 28 days, aerobically at 
37ºC. Percentages of survival at 15th and 28th day are below 22 % and vary according to the 
strain (fig. 3). In B. anthina FC0974 and FC0967 and in B. cepacia IST408 the mucoid 
isolates show higher survival abilities during the entire experiment. The opposite occurs in B. 
vietnamiensis PC259 and B. multivorans D2095 in which the percentage of survival is higher 
in the nonmucoid variant, although most of the differences are not statistically significant. B. 
multivorans ATCC17616 and B. phymatum STM815 show a higher survival ability of the 
mucoid isolate at day 15 but the percentages at day 28 are similar to the nonmucoid variant. 
B. dolosa CEP0743 mucoid isolate and nonmucoid variant have no differences in the 
percentage of survival during the entire experiment. 
 
 
 
 
 
Figure 3 – Ability to survive in M63 minimal medium without a carbon source of 8 Burkholderia isolates 
and the respective nonmucoid variants obtained under nutrient starvation: B. multivorans ATCC17616, B. 
vietnamiensis PC259, B. anthina FC0974 and FC0967, B. multivorans D2095, B. dolosa CEP0743, B. 
phymatum STM815 and B. cepacia IST408. Percentages of survival at day 15 for mucoid parental strains 
( ) and nonmucoid variants ( ) and at day 28 for mucoid parental strains ( ) and nonmucoid variants ( ) are 
shown. T-tests were performed using GraphPad InStat 3.10 software. P-values between 0.01 and 0.05 were 
considered as significant (*) and higher than 0.05 as not significant compared to the mucoid isolates. 
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3.3  Virulence in G. mellonella 
To evaluate differences in virulence among cultures, mucoid and nonmucoid bacteria 
were injected into G. mellonella model of infection and larvae survival rate was followed for 
7 days. The results allowed the distinction of three groups (fig. 4). The first group includes B. 
multivorans ATCC17616 and B. dolosa CEP0743, whose survival rates of mucoid isolates 
and nonmucoid variants were similar during the entire experiment. The second group 
encompasses B. multivorans D2095 and B. anthina FC0974 in which the mucoid strains 
presented a higher virulence at day 4 but a similar virulence at day 7, in comparison to the 
nonmucoid variants. The third group consists on the remaining strains, B. vietnamiensis 
PC259, B. cepacia IST408, B. anthina FC0967 and B. phymatum STM815 showing a more 
acute virulence in the mucoid isolate in comparison to the nonmucoid variant, throughout the 
experiment. 
 
                          
 
                          
 
                
 
Figure 4 – Percentage of survival of G. mellonella larvae after being injected with the mucoid isolates (♦) 
and the respective nonmucoid variants (□) of: B. multivorans ATCC17616, B. dolosa CEP0743, B. 
multivorans D2095, B. anthina FC0974, B. vietnamiensis PC259, B. cepacia IST408, B. anthina FC0967, 
B. phymatum STM815. Control larvae (●) were injected with MgSO4 with ampicillin 1.2 mg/ml. 
Triplicates of 10 larvae were injected with approximately 105 CFUs of each mucoid or nonmucoid strains, 
with the exception of B. multivorans D2095, B. cepacia IST408 and B. phymatum STM815 for which it 
was used 7x105, 104 and 107 CFUs, respectively. 
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3.4  Phenotypic characterization 
In order to identify possible differences between mucoid and nonmucoid Burkholderia 
cells, mucoid isolates and nonmucoid variants obtained under nutrient starvation of B. 
multivorans D2095, B. multivorans ATCC17616, B. dolosa CEP0743 and B. cepacia IST408 
were tested for several phenotypic properties. All the mucoid/nonmucoid pairs revealed 
identical growth curves in MM liquid medium at 37ºC (fig. 5). 
 
 
              
 
              
 
Figure 5 – Growth curves for mucoid (♦) and nonmucoid (□) cells of B. multivorans D2095 and 
ATCC17616, B. dolosa CEP0743 and B. cepacia IST408, grown in MM medium at 37ºC and 250 rpm. 
These results are the mean values of three independent experiments. 
 
Motility tests were performed by inoculating bacteria onto semi-solid medium. Some 
differences were evidenced between mucoid and nonmucoid bacteria, however those 
variations do not follow a regular pattern (fig. 6). While in B. multivorans D2095 the 
nonmucoid variant does more swimming and swarming than the mucoid isolate, in B. 
multivorans ATCC17616 the swimming is higher but the swarming is lower. On the other 
hand, B. dolosa CEP0743 and B. cepacia IST408 show increased swimming of the mucoid 
isolate but almost no difference in swarming. 
In relation to oxidative stress, H2O2 and cumene hydroperoxide susceptibilities were 
tested (fig. 6). No biologically relevant differences were observed with the exception of B. 
multivorans ATCC17616 and B. dolosa CEP0743 that showed, respectively, a slight increase 
and decrease of H2O2 susceptibility of the nonmucoid variant in comparison to the mucoid 
isolate. 
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Figure 6 – Phenotypic comparison between mucoid isolates ( ) and nonmucoid variants ( ) of B. 
multivorans D2095 (A) and ATCC17616 (B), B. dolosa CEP0743 (C) and B. cepacia IST408 (D). 
Swimming and Swarming motilities were assayed in 0.3 % and 0.5 % agar plates, respectively, spotted 
with 5 µl bacterial cultures and incubated for 24h at 37ºC. H2O2 (30 %), Cumene hydroperoxide (10 %) and 
SDS (10 %) susceptibility were determined after a 24 h incubation at 37ºC by measuring the diameter of 
cell growth inhibition. Siderophores production was assessed by spotting CAS-MM plates with 5 µl 
bacterial cultures and measuring the yellow halo after 48 h of incubation at 37ºC. Biofilm production was 
determined after a 24 h incubation at 37ºC in S medium. Hydrophobicity of the cells was determined by the 
BATH method after an overnight incubation in MM liquid medium at 37ºC. These results are the mean 
values of three independent experiments.  T-tests were performed using GraphPad InStat 3.10 software. It 
was considered P-values under 0.01 as very significant (**), between 0.01 and 0.05 as significant (*) and 
higher than 0.05 as not significant compared to the mucoid isolates. 
 
To evaluate possible differences in membrane constitution, detergent (SDS) 
susceptibility and LPS production were assessed. SDS susceptibility is higher in the 
nonmucoid variant of B. multivorans D2095 than in the mucoid isolate. The other strains 
showed no significant differences between mucoid and nonmucoid bacteria (fig. 6). 
Nevertheless LPS band pattern remains similar in all the four strains tested (Annex II fig. A1). 
The four pairs of mucoid/nonmucoid Burkholderia cells were also screened for 
siderophores production using the CAS assay. By this method a blue-to-yellow color change 
in the solid CAS plate is observed when the siderophores remove the iron from de Fe-CAS-
HDTMA complex in the medium. Siderophore excretion is indicated by the diameter of the 
yellow halo around colonies. The results showed that in all the four strains the nonmucoid 
variants produced a higher amount of siderophores in comparison to the mucoid wild-types. 
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However only B. multivorans D2095 and B. cepacia IST408 seemed to have biologically 
significant differences (fig. 6). 
The total biofilm formed by each strain was quantified after 24 h and 48 h of incubation 
in S medium at 37ºC. The amount of biofilm varied between species and significant 
differences were observed between mucoid and nonmucoid cells. In B. multivorans D2095 
and B. dolosa CEP0743 the nonmucoid variants formed more biofilm than the mucoid isolates 
at 24h (fig. 6). On the other hand B. multivorans ATCC17616 and B. cepacia IST408 seemed 
to behave differently as the mucoid WT formed more biofilm than the nonmucoid derivative. 
To understand if differences in biofilm formation were related to cell hydrophobicity, 
cell surface hydrophobicity was determined using the Bacterial Adhesion to Hydrocarbon 
(BATH) method. Mucoid isolates revealed to be more hydrophobic than the nonmucoid 
variants in B. multivorans ATCC17616 and B. dolosa CEP0743 with differences of 17 and 47 
%, respectively. The opposite occurs with B. cepacia IST408 in which the mucoid isolate 
shows no hydrophobicity while the nonmucoid variant is almost 35 % hydrophobic. In B. 
multivorans D2095 both mucoid and nonmucoid bacteria are very hydrophobic (around 70 
%), with no relevant differences between them (fig. 6). 
 
 
Figure 7 – Susceptibility to antibiotics of B. multivorans D2095 mucoid isolate ( ) and nonmucoid variant 
( ), B. multivorans ATCC17616 mucoid isolate ( ) and nonmucoid variant ( ), B. dolosa CEP0743 mucoid 
isolate ( ) and nonmucoid variant ( ) and B. cepacia IST408 mucoid isolate ( ) and nonmucoid isolate ( ). 
Susceptibility to antibiotics was evaluated after a 24 h incubation at 37ºC by measuring the diameter of cell 
growth inhibition (Pip, piperacillin; Taz, tazobactam; Cip, ciprofloxacin; Cef, ceftazidime; Ami, amikacin). 
These results are the mean values of three independent experiments. T-tests were performed using 
GraphPad InStat 3.10 software. It was considered P-values under 0.01 as very significant (**), between 
0.01 and 0.05 as significant (*) and higher than 0.05 as not significant compared to the mucoid isolates. 
 
Variation in antimicrobials susceptibility was tested by disc diffusion assay. β-lactams 
(ceftazidime, imipenem and aztreonam), an aminoglycoside (amikacin) and a quinolone 
(ciprofloxacin) were tested and the results are shown in figure 7. In B. multivorans D2095 and 
B. cepacia IST408 the nonmucoid variants were, in general, more susceptible than the mucoid 
parental strains to almost all the antibiotics analysed. In fact, in the case of aztreonam the 
mucoid isolate of B. multivorans D2095 was totally resistant to the antimicrobial while the 
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nonmucoid variant was highly sensitive. In contrast, B. multivorans ATCC17616 and B. 
dolosa CEO0743 did not evidence major differences in the susceptibilities to any of the 
antibiotics tested. Despite the differences between mucoid and nonmucoid cells of B. 
multivorans ATCC17616 are statistically significant for ciprofloxacin resistance, they have 
almost no impact in terms of biological meaning. 
 
3.5  Expression profile of B. multivorans ATCC17616 mucoid isolate and 
nonmucoid variant 
To complement the phenotypic assays, a transcriptional study was performed. B. 
multivorans ATCC17616 mucoid isolate and the respective nonmucoid variant obtained under 
nutrient starvation were compared. For that study, a dual-species custom Burkholderia 
microarray (Bcc1sa520656F) produced by Affymetrix was used. One of the species 
represented in the array is B. multivorans ATCC17616, with gene coverage of 99.8 %. Both 
mucoid and nonmucoid B. multivorans ATCC17616 were grown in SM medium until early 
stationary phase, in which high-molecular-mass EPS is not yet recovered from the mucoid 
strain liquid culture. Total RNA was extracted, converted to cDNA, biotin-labelled and 
hybridized in triplicate to the array. Hybridization intensities from the nonmucoid variant 
were compared to those of the mucoid isolate using dChip (≥1.3-fold-change lower 
confidence bound with a resulting false discovery rate of 2.4 %). The results indicated a total 
of 174 genes differentially expressed, of which 74 showed a significantly increased 
expression and the remaining 100 a significantly decreased expression (See Annex II tables 
A2 and A3). 
All the genes were divided into clusters of orthologous groups (COGs) (fig. 8). Many of 
the genes with increased expression were related to motility, while the genes with decreased 
expression include genes related to type VI secretion system, inorganic ion and amino acid 
transport and metabolism and cell wall, cell membrane and envelope biogenesis. Genes 
related to transcription, signal transduction and intracellular traffic have either over-expressed 
as under-expressed genes (table 4). 
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Figure 8 – Functional distribution of COGs of genes with altered expression when comparing B. 
multivorans ATCC17616 nonmucoid variant with the respective mucoid parental isolate. A total of 174 
genes with a statistically significant difference in expression were obtained by using a custom Affymetrix 
Burkholderia GeneChip. 
 
 
Table 4 - Selection of a set of differentially expressed genes when comparing the transcriptome of B. 
multivorans ATCC17616 nonmucoid variant with that of the mucoid isolate, separated by functional 
groups. 
Functional class Gene identifier 
LB-
FC* 
Gene 
name Description 
Flagellar 
synthesis, 
motility, adhesion 
and chemotaxis 
Bmul_0151 2,9 fliC flagellin domain protein 
Bmul_0163 1,3 motB OmpA/MotB domain protein 
Bmul_3009 1,3 flgL flagellar hook-associated protein 3 
Bmul_3017 1,3 flgE flagellar basal body FlaE domain protein 
 Bmul_3018 1,3 flgD flagellar hook capping protein 
 Bmul_3019 1,5 flgC flagellar basal body rod protein FlgC  
 Bmul_3021 1,7 flgA flagellar basal body P-ring biosynthesis protein FlgA  
 Bmul_0166 1,3 cheW CheW protein  
 Bmul_3362 1,3 era methyl-accepting chemotaxis sensory transducer 
 Bmul_0042 1,3 fliN flagellar motor switch protein FliN 
 Bmul_1610 -1,9 fimC pili assembly chaperone 
 Bmul_1611 -1,4 fimD fimbrial biogenesis outer membrane usher protein 
 Bmul_1612 -2,8 fima fimbrial protein 
 Bmul_2818 1,5 pilB type II secretion system protein E 
Virulence and 
pathogenesis 
Bmul_3709 -2,4 adh hemolysin-type calcium-binding region 
Bmul_2923 -1,3 bcsE type VI secretion-associated protein, ImpA family 
 Bmul_2927 -1,3 bcsI type VI secretion system lysozyme-related protein 
 Bmul_2928 -1,4 bcsJ type VI secretion system effector, Hcp1 family 
 Bmul_2929 -1,5 bcsK type VI secretion protein, EvpB/VC_A0108 family 
 Bmul_2930 -1,9 bcsL type VI secretion protein, VC_A0107 family 
 Bmul_5730 -1,4 - type VI secretion system Vgr family protein 
0 5 10 15
Function unknown (S)
General function prediction only (R)
Secondary metabolites biosynthesis and transport (Q)
Inorganic ion transport and metabolism (P)
Lipid transport and metabolism (I)
Coenzyme transport and metabolism (H)
Nucleotide transport and metabolism (F)
Amino acid transport and metabolism (E)
Carbohydrate transport and metabolism (G)
Energy production and conversion (C)
Posttranslational modification, protein turnover (O)
Intracellular traffic (U)
Cell motility (N)
Cell wall, membrane, envelope biogenesis (M)
Signal transduction (T)
Defense mechanisms (V)
Cell division (D)
Replication, recombination, and repair (L)
Transcription (K)
Translation, ribossomal structure and biogenesis (J)
Increased expression
Decreased expression
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Cell Wall / 
membrane 
Bmul_2607 -1,4 - ABC transporter related 
Bmul_2608 -1,4 - ABC-2 type transporter 
 Bmul_0320 1,4 vacJ VacJ family lipoprotein 
 Bmul_1006 1,3 dgk diacylglycerol kinase 
 Bmul_1318 -1,4 mscL large conductance mechanosensitive channel protein 
 Bmul_4401 -1,3 - glycosyl transferase group 1 
 Bmul_5944 -6,6 - methyltransferase type 12 
 Bmul_5945 -4,8 - methyltransferase type 12 
Transcription 
regulators 
Bmul_1606 -1,7 orbS RNA polymerase, sigma-24 subunit, ECF subfamily 
Bmul_1761 1,3 - transcriptional regulator, LysR family 
 Bmul_2098 1,3 - transcriptional regulator, BadM/Rrf2 family 
 Bmul_2372 1,5 - transcriptional regulator, GntR family 
 Bmul_2393 -2,7 cspA cold-shock DNA-binding domain protein 
 Bmul_2442 1,4 nusB transcription antitermination protein NusB  
 Bmul_2557 -2,3 - transcriptional regulator, LysR family 
 Bmul_2962 -1,3 - transcriptional regulator, LysR family 
 Bmul_4295 -1,3 - LysR family transcriptional regulator 
 Bmul_4936 -1,3 - transcriptional regulator, AraC family 
Signal transdution Bmul_3051 1,5 - putative signal transduction histidine kinase 
 Bmul_3471 -1,4 - diguanylate phosphodiesterase 
 Bmul_4254 1,3 - UspA domain protein 
 Bmul_4389 -1,7 - putative transcriptional regulator, Crp/Fnr family 
 Bmul_4947 -1,5 - response regulator receiver sensor signal transduction histidine 
kinase 
 Bmul_5122 -1,5 - diguanylate cyclase/phosphodiesterase 
 Bmul_3737 -1,3 - transcriptional regulator, LuxR family 
 Bmul_5766 -1,3 - two component transcriptional regulator, LuxR family 
 Bmul_0164 1,4 cheY response regulator receiver protein 
Energy 
production and 
conversion 
Bmul_2649 -1,3 hmpA oxidoreductase FAD/NAD(P)-binding domain protein 
Bmul_4546 1,3 coxS (2Fe-2S)-binding domain protein 
Bmul_5248 1,4 Ndh FAD-dependent pyridine nucleotide-disulphide oxidoreductase 
Bmul_5760 -1,3 - cytochrome c class I 
 Bmul_5761 -1,3 coxA cytochrome c oxidase subunit I 
 Bmul_5907 1,3 - cytochrome c, class I 
 Bmul_5639 -1,4 - alcohol dehydrogenase zinc-binding domain protein 
Amino acid 
transport and 
metabolism 
Bmul_0879 -1,5 glnB nitrogen regulatory protein P-II  
Bmul_2990 -1,3 potD extracellular solute-binding protein  
Bmul_3036 1,4 dppF dipeptide transporter ATP-binding subunit  
 Bmul_3701 -1,4 ldcC lysine/arginine decarboxylase 
 Bmul_3702 -1,3 adiC arginine:agmatin antiporter  
 Bmul_3719 1,27 pub FAD dependent oxidoreductase 
 Bmul_4502 -1,4 - ABC transporter related 
 Bmul_5003 -1,3 - polar amino acid ABC transporter, inner membrane subunit 
Inorganic ion 
transport and 
metabolism 
Bmul_2003 -2,1 katE catalase 
Bmul_2016 1,3 phoU phosphate uptake regulator, PhoU 
Bmul_3335 -1,3 - transport system permease 
 Bmul_3336 -1,3 - periplasmic binding protein 
 Bmul_3337 -1,3 hmuS haemin-degrading family protein 
 Bmul_3423 1,4 - 2-aminoethylphosphonate ABC transporter/binding protein 
 Bmul_3736 -1,3 - natural resistance-associated macrophage protein 
 Bmul_4079 -2,4 mgtA magnesium-translocating P-type ATPase 
 Bmul_5946 -3,0 - rieske (2Fe-2S) domain protein 
  Bmul_5949 -1,4 - rieske (2Fe-2S) domain protein 
*LB-FC, lower bound of fold-change; 
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In order to validate the data obtained by microarray analysis, the expression of some 
genes related to virulence, motility, transcriptional regulation and signal transduction was 
analysed by qRT-PCR. Although most of the genes have higher fold-changes when analysed 
by qRT-PCR, the results are in agreement with microarray (table 5). 
 
Table 5 - Quantitative real-time RT-PCR analysis performed in B. multivorans ATCC17616 nonmucoid 
variant in comparison to the mucoid isolate. Data are normalized to proC gene levels. 
Gene Microarray lower bound of fold-change 
Real-time fold-
change ± sd 
Bmul_2929 (bcsK) -1.5 -5.0 ± 1.0 
Bmul_3021 (flgA) 1.7 4.2 ± 1.4 
Bmul_4936 -1.3 -1.5 ± 0.4 
Bmul_4389 -1.7 -10.1 ± 3.8 
Bmul_5122 -1.5 -11.6 ± 3.0 
 
The over-expressed motility genes fliC, fliN, flgA/C/D/E/L are mostly involved in 
flagellar assembly. This possibly indicates that the nonmucoid variant is more mobile than the 
mucoid isolate. Also chemotaxis genes similar to cheW and aer found in other bacteria 
showed increased expression in the nonmucoid variant, possibly helping bacteria to find 
places with more oxygen and carbon sources. In opposition, some fim genes related to the 
synthesis of the pili were under-expressed. These genes are involved in adhesion of the cells 
to surfaces which contributes to the idea that the nonmucoid cells are less adherent and, 
consequently, more mobile than the mucoid cells. These results agree with the phenotypic 
results showed earlier, which evidenced a higher swimming ability and a lower biofilm 
formation of B. multivorans ATCC17616 nonmucoid variant. 
On the other hand, 7 genes related to type VI secretion system had a decreased 
expression in the nonmucoid variant. This secretion system is believed to play a specific role 
in the maintenance of Burkholderia cells in an eukaryotic host and to help them defending 
against other bacteria in the environment (67). 
In relation to energy and intermediary metabolism, it was observed that several genes 
involved in inorganic ion and amino acid transport and metabolism were under-expressed in 
the nonmucoid variant in comparison with the mucoid isolate. Most of these genes encode for 
binding proteins and transporters, however, no particular metabolic pathway was affected. 
Genes related to energy production and conversion had differences in expression but did not 
evidence a tendency. Genes like Bmul_2649 and Bmul_5639 were under-expressed in the 
nonmucoid variant and encode a protein highly homologue to nitric oxide dioxygenase 
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(hmpA) and an alcohol dehydrogenase zinc-binding domain protein, respectively. Genes like 
Bmul_4546 and Bmul_5248 were over-expressed and encode a putative aerobic-type carbon 
monoxide dehydrogenase (coxS) and a FAD-dependent pyridine nucleotide-disulphide 
oxidoreductase, respectively (table 3). These proteins enable bacteria to use different 
compounds as inorganic sources of energy. Differences in expression can indicate that 
bacteria are able to regulate their metabolism according to their needs and to the 
environmental conditions. In addition, the gene encoding catalase, responsible for the 
decomposition of H2O2 to water and oxygen, was under-expressed in the nonmucoid variant. 
H2O2, nitric oxide and carbon monoxide are three harmful compounds to the cell and the 
action of enzymes that use or degrade them is essential to the maintenance of bacterial cells. 
In fact, the higher susceptibility of the nonmucoid variant of B. multivorans ATCC17616 to 
H2O2 (fig. 6) can be due to this decreased expression of catalase.  
It was observed a decrease in expression in a number of genes involved in cell wall, cell 
membrane and envelope biogenesis in the nonmucoid variant in comparison with the mucoid 
isolate. These genes include two ABC-transporters, two methyltransferases, one glycosyl 
transferase and one channel protein sensitive to pressure or hypoosmotic shock.  Contrariwise, 
genes Bmul_0320 and Bmul_1006 encoding a VacJ family lipoprotein and a diacylglycerol 
kinase, respectively, were over-expressed. 
In the categories of transcriptional regulators and signal transduction it was observed an 
increased expression of the universal stress protein family UspA, which helps bacteria to 
survive during the exposure to stress agents. Also members of signal transduction pathways 
like the histidine kinase Bmul_4947 and elements of Crp/Fnr and LuxR families were under-
expressed in the nonmucoid variant, as well as two diguanylate phosphodiesterases, Bmul_ 
3471 and Bmul_5122. These two last proteins are probably related to the degradation of the 
signal molecule cyclic di-GMP and they both have regions with high similarity to EAL 
domains which may be involved in the regulation of bacterial adhesion. 
It was observed an over-expression of genes belonging to the families of transcriptional 
regulators LysR, BadM/Rrf2 and GntR and of the transcription antitermination protein NusB, 
involved in the regulation of rRNA biosynthesis. Under-expressed genes encompass 
transcriptional regulators belonging to the families LysR and AraC, the RNA polimerase 
sigma-70 factor and a cold-shock DNA-binding domain protein (CSP). Despite CSP has a 
basal level of expression under normal conditions, it is increased when an abrupt drop in 
growth temperature occurs. Although its function is not totally understood, it is thought to 
regulate mRNA degradation, rRNA translation and the rate of transcription termination (68). 
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One gene encoding a transcriptional regulator significantly under-expressed was 
Bmul_2557, belonging to LysR-family of transcriptional regulators. This family encompasses 
a wide number of highly conserved LysR-type transcriptional regulators (LTTRs) that can be 
involved in cellular processes such as amino acid biosynthesis, CO2 fixation, antibiotic 
resistance, degradation of aromatic compounds, nodule formation of nitrogen-fixing bacteria, 
and synthesis of virulence factors (69). 
 
3.6  Molecular cloning 
One of the genes whose expression was decreased in the nonmucoid variant of B. 
multivorans ATCC17616 was the gene Bmul_2557. As referred above, Bmul_2557 gene 
encodes for a LysR-family transcriptional regulator possibly involved in a wide variety of 
metabolic processes. Gene expression of Bmul_2557 was compared between nonmucoid 
variants and the respective mucoid isolates of B. multivorans ATC17616 and D2095, B. 
cepacia IST408, B. anthina FC0967 and B. vietnamiensis PC259. In all of these strains the 
LysR-family transcriptional regulator was under-expressed in the nonmucoid variant (fig. 9). 
 
 
 
 
 
Figure 9 - Quantitative real-time RT-PCR analysis of transcript levels of the gene Bmul_2557 in the B. 
multivorans ATC17616 and D2095, B. cepacia IST408, B. anthina FC0967 and B. vietnamiensis PC259 
nonmucoid variants in comparison to the mucoid isolates. Data are normalized to trpB gene levels. 
 
To evaluate the importance of this gene in the mucoid-to-nonmucoid conversion and in 
bacteria virulence a strategy to knock-out the gene was initiated (fig. 10). The upstream and 
downstream regions of the gene were cloned into the pBCKS- cloning vector and a 
trimethoprim (Tp) cassette was inserted between them. The resulting plasmid, pAT812-Tp, 
will then be introduced into B. multivorans ATCC17616 and a double recombination with its 
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genome will allow the identification of both wild-type and mutant cells in which the gene 
Bmul_2557 will be replaced by the Tp cassette.  
 
 
 
 
 
 
   
Figure 10 – Strategy to eliminate Bmul_2557 of B. 
multivorans ATCC17616 genome by replacing it 
by a trimethoprim (Tp) cassette. The stages of the 
cloning strategy which have already been 
concluded are represented in darker color, while 
the following steps are lighter coloured. 
lacZ – gene coding for β-galactosidase; Cm – gene 
for chloramphenicol resistance. Amp – gene for 
ampicillin resistance. Km – gene for kanamycin 
resistance. TP – gene for trimethoprim resistance. 
Upstream (L) and downstream (R) regions were 
cloned into pBCKS- and pDrive vectors, 
respectively, resulting in pAT312 and pAT712. 
The R region was then cloned into pAT312. A TP 
cassette was inserted between L and R originating 
pAT812-Tp. This final vector will be introduced 
into B. multivorans ATCC17616 and recombined 
with a genomic region.  
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4.  Discussion 
 
Mucoid-to-nonmucoid transition is a very common phenomenon during bacterial 
infections and has already been described for different Burkholderia species, including B. 
cenocepacia, B. multivorans and B. vietnamiensis (41). Two clonal Burkholderia multivorans 
strains, sequentially isolated from a chronically infected CF patient have been previously 
characterized in our laboratory (43). These isolates represent a morphotype variation since the 
first, D2095, is mucoid and the second, D2214, isolated 6 months later, is nonmucoid. 
Differences in the expression of virulence factors, virulence in G. mellonella model of 
infection and ability to survive under nutrient limitation were observed (43). Further studies 
indicated that morphotype variation did never occur when the strains were grown under 
standard conditions (rich medium, aerobically at 37ºC for 7 days). However, mucoid-to-
nonmucoid conversion was observed when D2095 was submitted to some antimicrobials, 
nutrient starvation, high or low temperatures, high osmolarity and oxidative stress agents (44). 
Some of these stress conditions, as well as iron limitation, anaerobic conditions and growth 
within human macrophages can also trigger morphotype alteration in B. pseudomallei (70, 
71). 
In this study we wanted to understand if stress conditions could also trigger mucoid-to-
nonmucoid variation in other Bcc and non-Bcc species both from clinical and environmental 
source. A total of sixteen mucoid strains were tested and the results showed that eight (50 %) 
of them gave rise to nonmucoid variants after being incubated for 28 days under nutrient 
limitation (fig. 1). These strains include clinical and environmental strains and two non-Bcc 
strains, which may indicate that the response to this stress is a common feature of the 
Burkholderia genus. In the presence of ciprofloxacin five (30 %) strains had originated 
nonmucoid variants (fig. 1). Contrary to nutrient starvation, in the presence of ciprofloxacin 
all the strains that originated nonmucoid variants were clinical Bcc strains. 
These results contribute to the idea that Burkholderia strains are able to respond to 
stresses and to adapt to different growth conditions according to their ecological niche. This 
process can occur through specific alterations of pathogenicity and phenotypic traits during 
the adaptation of clinical isolates to environment and vice-versa (72–74). Also, Vial and co-
workers have shown that phase variation helps the clinical isolate B. ambifaria HSJ1 to 
colonize different ecological niches, as lungs or rizosphere, by changing the type and amount 
of virulence factors that are produced (75).  
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Normal airway mucus is mainly composed of mucin glycoproteins (76). The sputum of 
CF patients’ lungs is characterized by a significant increase in the amount of these 
macromolecules as well as by the presence of other large nonmucin polymers such as DNA, 
filamentous actin, proteoglycans, biofilms and polypeptides released from inflammatory cells 
(reviewed in (77)). The nutrient composition of the sputum is known to influence several 
bacterial functions such as the production of virulence factors, motility, biofilm production, 
and virulence (reviewed in (78)). In fact, when CF sputum is used as the unique carbon source 
for the growth of P. aeruginosa the cells evidence major differences in their physiology, 
including the use of amino acids as a carbon source (78). To compare the ability of mucoid 
isolates and nonmucoid variants to survive nutrient limitation, the strains were incubated in 
minimal medium for 28 days (fig. 3). After 15 days of incubation in three of the eight strains 
tested the nonmucoid variant suffered a significantly higher decrease in survival, what seem 
to indicate that the mucoid isolates were better adapted to starvation conditions. The opposite 
occurs in B. multivorans D2095 in which the nonmucoid variant had a higher survival 
capacity. However, after 28 days of incubation, the percentages of survival experienced a 
decrease to less than 11 % and the observed differences were not biologically relevant. Since 
EPS production is an energy- and carbon-consuming process (79, 80) nonmucoid variants 
should save that energy and resources to other metabolic processes. Therefore it would be 
expected a higher survival level in starvation conditions in comparison with the mucoid 
parental strains. 
Virulence assays in G. mellonella suggested that the majority of the nonmucoid variants 
were less virulent at day-4 of infection. However, at day-7 half of the strains tested presented 
a similar larvae mortality for the mucoid and nonmucoid cells (fig. 4). This results are in 
agreement with our previous study which have revealed that the clinical mucoid isolate B. 
multivorans D2095 was more virulent than its sequential nonmucoid isolate D2214 (43). 
Also, studies performed with mucoid isolates and spontaneous nonmucoid variants of B. 
ambifaria evidenced that the second was, in general, less virulent than the first using G. 
mellonella as the model of infection. On the other hand strains of B. cenocepacia, the most 
virulent Bcc specie, are mainly nonmucoid and it was shown that some virulence factors seem 
to be over-expressed in the nonmucoid isolates when compared to the mucoid isolates (41, 
81). Besides, data modeling showed that, in general, the intensity of mucoidy is inversely 
correlated with the rate of decline in pulmonary function (42). Therefore, the relation between 
mucoid and nonmucoid cells’ virulence in G. mellonella appears to be strain dependent. 
Discussion 
29 
 
Burkholderia species express a wide variety of virulence factors that may be directly or 
indirectly related to its virulence. To try to understand the virulence results in G. mellonella, a 
phenotypic characterization was performed of four Bcc strains from three different species 
commonly isolated from CF patients’ lungs. The results are summarized in table 6. 
 
Table 6 – Phenotypic comparison of nonmucoid variants vs. mucoid isolates of Burkholderia species. 
 
(1) comparison of resistance;   (2) the first line is for cumene hidroperoxide and the second for H2O2. 
 
Some of the phenotypic traits remained similar between mucoid and nonmucoid cells of 
all strains, including growth rate and LPS pattern. Others like survival in starvation conditions 
and resistance to detergents and to oxidative agents had differences in only one or two strains 
(table 6). 
Our main goal was to understand which characteristics could be related to mucoid-to-
nonmucoid variation and, consequently, would always be altered between the two types of 
cells. Although the variations did not evidence a regular tendency in all of the four strains, the 
results showed that swimming motility and biofilm formation were always altered between 
mucoid and nonmucoid cells (table 6). Swimming motility is important in the dissemination 
of bacteria through the organism and it is closely related to the production of flagella, a 
virulence factor common to all Bcc species (23). Bcc species can express one or two types of 
flagellin that are distinguished by size and RFLP patterns of fliC gene (82). Microarrays have 
shown that many genes involved in flagellar assembly are over-expressed in the nonmucoid 
variant of B. multivorans ATCC17616 which agrees with its higher swimming motility. Some 
studies have shown that flagellin mutants had pronounced deficiencies in invasion of human 
lung cells, and a highly decreased capacity to severely injure mice (23, 83). Thereby the 
nonmucoid variants of both B. multivorans strains and the mucoid isolates of B. dolosa 
CEP0743 and B. cepacia IST408 may be more able to invade human lung cells. 
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Flagella are also related to the adhesion of bacterial cells to the host and to the 
formation of biofilms (84). Biofilms can be produced by many Bcc species colonizing the 
lungs of CF patients, suggesting that its production may be related to the protection from host 
antimicrobial defenses (85). The role of biofilms in antimicrobials resistance is controversial 
as some studies show that biofilms increase its resistance (86, 87) while others, including this 
work, do not evidence any correlation (88). The expression profile analysis showed a decrease 
in genes related to the synthesis of pili, also involved in the adhesion of bacterial cells to the 
surfaces, in the nonmucoid variants of B. multivorans ATCC17616. This fact contributes to 
the idea that these nonmucoid variants are more mobile and less adherent to the host cells. It 
would be interesting to evaluate differences in adhesion and invasion of human tissues 
between all the mucoid isolates and respective nonmucoid variants. 
Siderophores production is also different in three of the four strains tested (table 6). Iron 
is a vital element for the bacterial growth since it is an essential co-factor of important 
enzymes involved in primary and secondary metabolic pathways. Inside the human host iron 
is usually tightly bound to proteins like lactoferrin, transferrin, ferritin and hemoproteins 
leaving only a small amount of free serum iron (89). For this reason bacterial pathogens have 
to develop mechanisms to acquire iron. One method is the production of siderophores which 
are small-molecule compounds (generally <1 kDa) with high-affinity for ferric iron. Members 
of Bcc bacteria can produce up to four different siderophores including ornibactin, pyochelin, 
cepabactin and cepaciachelin which are thought to be essential for the expression of full 
pathogenicity in several hosts namely Caenorhabditis elegans and G. mellonella (24, 90). The 
results show that that, in general, the nonmucoid variants produce more siderophores than the 
mucoid isolates, possibly indicating its higher ability to acquire iron from the medium. This 
increase could lead to a higher activity of iron-dependent enzymes with impact on metabolic 
pathways, although significant alterations were not observed in microarray analysis. On the 
other hand, some of the results of this work fit the expected results for the absence of the fur 
gene demonstrated by Yuhara and co-workers (2008) in B. multivorans ATCC17616, 
including a higher production of siderophores, a higher sensitivity to reactive oxygen species 
like H2O2 and a decreased expression of catalase and of an enzyme homologue to nitric oxide 
dehidrogenase (91). However, there were no significant differences in the expression of the 
fur gene and no conclusions can be taken. Moreover, this increase in siderophores production 
could lead to an excess of iron that would inhibit enzyme activity and become toxic to the cell 
(92). Nevertheless as no differences in growth were observed the major metabolic processes 
do not seem to be altered and this hypothesis is not probable to happen. 
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Relatively to the susceptibility to antimicrobials only two of the four strains have 
evidenced differences between mucoid and nonmucoid cells (table 6). However, when those 
differences exist, the nonmucoid variants are always more susceptible than the parental 
mucoid isolates. These results are in agreement with our previous study in which the 
nonmucoid isolate B. multivorans D2214 is more susceptible to antibiotics than its clonal 
mucoid isolate D2095 (43). Due to antibiotic therapies administered to CF patients it would 
be expected a higher resistance of the nonmucoid variants. One hypothesis is that the EPS 
produced by the mucoid bacteria could be capable of protecting the cell against the action of 
several antibiotics. 
As these results showed that morphotype alteration is possibly related to different 
phenotypic properties we hypothesized that some other alteration, possibly in a regulatory 
protein, could be responsible for this morphotype variation. To evaluate that possibility, a 
molecular strategy to knock-out the gene Bmul_2557 was initiated. Bmul_2557 encodes a 
LysR-family transcriptional regulator that is under-expressed in the nonmucoid variants of B. 
multivorans ATCC17616, B. multivorans D2095, B. cepacia IST408, B. anthina FC0967 and 
B. vietnamiensis PC259 (fig. 9). Future studies include the evaluation of the role of gene 
Bmul_2557 in the cell and its importance on the regulation of mucoid-to-nonmucoid 
variation. 
In conclusion, this study confirms that morphotype variation can occur in a wide range 
of Burkholderia species, belonging or not to the Bcc, by exposing the cells to different 
laboratory stress conditions. This variation appears to be related to the original ecological 
niche of bacteria. Also, it has shown that mucoid-to-nonmucoid alteration is a complex 
process that seems to relate to other phenotypic traits as motilility, biofilm formation and, in a 
lesser extent, to the production of siderophores. Further studies are needed to identify the 
mechanisms underlying this process and to understand the relationship between the multiple 
cellular properties. 
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Annex I 
 
 
A. Culture media composition (Formula / Liter of distilled water). 
 
 
15g/L of agar was added when necessary. 
 
LB Broth (Lennox) medium (conda-pronadisa) 
  
Enzymatic digest of casein (10 g), yeast extract (5 g), NaCl (5 g). 
Final pH: 7.3 ± 0.2 at 25°C 
 
Exopolysaccharide producing (S/SM) medium (29, 48) 
 
Solution 1 (500 ml of distilled water): Na2HPO4•2H20 (12.5 g), KH2PO4  (3 g), K2SO4 
(1 g), NaCl (1 g) 
Solution 2 (200 ml of distilled water): Yeast extract (1 g), casamino acids (1 g) 
Solution 3 (300 ml of distilled water): Glucose (in S medium) (20 g), Mannitol (in SM 
medium) (20 g)
Solutions 1, 2 and 3 were prepared and autoclaved separately. After cooled, solutions were 
mixed together and supplemented with MgSO4•7H2O (0.2 g), CaCl2•2H2O (0.01 g) and 
FeSO4•7H2O (0.001 g). 
 
Mannitol (MM) medium 
 
Yeast extract (2 g), mannitol (20 g) 
 
Yest extract mannitol (YEM) medium (41) 
 
Yeast extract (0.5 g), mannitol (4 g) 
 
Pseudomonas Isolation Agar (PIA) medium (BD) 
 
Bacto Peptone (20 g), MgCl2•6H2O (1.4 g), K2SO4 (10 g), Irgasan® (0.025 g), agar 
(13.6 g), glycerol (20 ml). Final pH: 7.0 ± 0.2 at 25ºC  
 
M63  minimal medium (45) (1 liter of 5X medium in distilled water) 
 
(NH4)2SO4 (10 g), KH2PO4 (68 g), FeSO4•7H2O (2.5 mg). Final pH adjusted to 7.  
 
Before being used the medium was diluted to 1X with sterile water and supplemented with 1 
ml of MgSO4•7H2O (1 M) and 10 ml of 20 % (w/v) carbon source. For the long-term nutrient 
starvation assays no carbon source was added. 
 
Swimming and Swarming Plates medium 
 
Swimming plates: Tryptone (400 mg), yeast extract (100 mg), CaCl2 (67 mg), Bacto 
agar (Difco) (1.5 g) 
Swarming plates: Tryptone (10 g), yeast extract (5 g), NaCl (5 g), glucose (5 g), Noble 
agar (Difco) (2.5 g)
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B. Composition of Solutions and Buffers. 
 
 
Tris-borate-EDTA (TBE) buffer (1 liter of 5X stock solution in distilled water) 
 
Tris base (54.45 g), boric acid (27.83 g), EDTA (3.99 g). Final pH adjusted to 8. 
 
  For PFGE run it was used TBE 0.5X. 
 
 
Chrome azurol S. (CAS) solution (63)  
 
Solution 1: 60.5 mg of CAS dissolved in 50 ml of distilled water 
Solution 2: 10 ml of 1 mM FeCl•6H2O, 10 mM HCl in distilled water 
Solution 3: 72.9 mg of HTMA dissolved in 40 ml of distilled water 
 
Under stirring, solutions 1, 2 and 3 were slowly mixed. The resulting dark blue 
solution was autoclaved and mixed with 900 ml of autoclaved MM medium 
 
 
Phosphate-buffered saline (PBS) (1 liter in distilled water) 
 
NaCl (8 g), KCl (0.2 g), Na2HPO4•H2O (1.8 g), KH2PO4  (0.24 g). 
Final pH adjusted to 7.4 
 
 
LPS solutions 
 
Lysis buffer: 2 % (w/v) SDS, 4 % (v/v) 2-mercaptoethanol, 10 % (v/v) glycerol, 1 M Tris pH 
6.8 and 0.1 % (w/v) bromophenol blue. 
Proteinase K digestion buffer: lysis buffer containing 2.5 mg/ml of proteinase K. 
Fixing reagent: 25 % (v/v) isopropanol in 7 % (v/v) acetic acid 
Oxidising reagent: 1.05 g periodic acid, 1 ml isopropanol, 200 µl 99.5 % acetic acid in 150 ml 
of distilled water. 
Staining solution: 4 ml of 20 % (w/v) silver nitrate added to 115 ml of distilled water with 350 
µl of NaOH (2mM) and 0.3 % (v/v) ammonium hydroxide 
Developing solution: 7.5 mg citric acid, 75 µl of 37 % (v/v) formaldehyde in 150 ml of 
distilled water. 
Stopping solution: 0.4 % (v/v) acetic acid 
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Annex II 
 
       Table A1. Gene-specific primers used for quantitative real-time RT-PCR. 
Gene 
identification Forward Primer Reverse primer 
Bmul_2929 (bcsK) CAGCTTCAGTACATCTTCTCGGTATC CCGCATCATCGCCTTCAG 
Bmul_3021 (flgA) GCGTCGCGCTCGTATCA TCAGTTGCTTCGCGGTGTT 
Bmul_4936 CGTTCAATCTGGCCAATCG ACACGTACTTCGGCTGATAATCC 
Bmul_4389 CCGGCTGCTTCTCAACTATTG CGAATGATGGCGATTGCA 
Bmul_2557 CACTCGTCACGCGTTCGAT GGTGGATCAGCCGCGTAT 
Bmul_5122 CGTGTCCGAGGTGAATTCG TCGCAGAGCCGGTTGAA 
 
 
  
Figure A1. SDS-PAGE analysis of LPS from proteinase K-digested whole-cell lysates of the mucoid 
parental isolates (P) and the nonmucoid variants (V) obtained under nutrient starvation of: B. multivorans 
ATCC17616 (1) and D2095 (2), B. dolosa CEP0743 (3) and B. cepacia IST408 (4). 
 
 
Table A2. Complete list of B. multivorans ATCC17616 nonmucoid variant genes with increased 
expression (>1.3-fold-change lower confidence bound) compared to the expression of the mucoid isolate. 
Probe set Locus Tag LB-FC* 
Gene 
name Description COG 
BCAL0130_a_at Bmul_0166 1,3 cheW CheW protein  NT 
BCAL0565_a_at Bmul_3019 1,5 flgC flagellar basal body rod protein FlgC  N 
BCAL1413A_x_at Bmul_1909 1,7 osmB putative osmosis-related lipoprotein  - 
BCAL1698_a_at Bmul_3036 1,4 dppF dipeptide transporter ATP-binding subunit  E 
BCAL3055_a_at Bmul_2442 1,4 nusB transcription antitermination protein NusB  K 
BCAL3201_a_at Bmul_2585 1,4 tolR protein TolR  U 
Bmul0042_at Bmul_0042 1,3 fliN flagellar motor switch protein FliN NU 
Bmul0151_at Bmul_0151 2,9 fliC flagellin domain protein N 
Bmul0163_a_at Bmul_0163 1,3 motB OmpA/MotB domain protein N 
Bmul0164_at Bmul_0164 1,4 cheY response regulator receiver protein T 
Bmul0314_a_at Bmul_0314 1,3 thiS thiamine biosynthesis protein ThiS H 
Bmul0320_at Bmul_0320 1,4 vacJ hypothetical protein M 
Bmul0322_x_at Bmul_0322 1,3 - hypothetical protein R 
Bmul0363_at Bmul_0363 1,6 - CutC family protein - 
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Bmul0434_at Bmul_0434 1,3 - hypothetical protein - 
Bmul0528_at Bmul_0528 1,3 kdsC 3-deoxy-D-manno-octulosonate 8-P phosphatase, YrbI 
family 
R 
Bmul0627_at Bmul_0627 1,3 dead DEAD/DEAH box helicase domain protein LKJ 
Bmul0760_at Bmul_0760 1,3 - hypothetical protein - 
Bmul0824_at Bmul_0824 1,4 cysG uroporphyrin-III C-methyltransferase H 
Bmul0830_at Bmul_0830 1,4 - hypothetical protein - 
Bmul0863_at Bmul_0863 1,3 - hypothetical protein S 
Bmul0978_at Bmul_0978 1,4 maf maf protein D 
Bmul0987_x_at Bmul_0987 1,3 mgsA methylglyoxal synthase G 
Bmul1006_at Bmul_1006 1,3 dgk diacylglycerol kinase M 
Bmul1182_at Bmul_1182 1,3 - hypothetical protein S 
Bmul1501_at Bmul_1501 1,3 - hypothetical protein - 
Bmul1573_at Bmul_1573 1,3 acd acyl-CoA dehydrogenase domain protein I 
Bmul1738_at Bmul_1738 1,4 - hypothetical protein - 
Bmul1761_at Bmul_1761 1,3 - transcriptional regulator, LysR family K 
Bmul2016_a_at Bmul_2016 1,3 phoU phosphate uptake regulator, PhoU P 
Bmul2044_at Bmul_2044 1,3 fabD acyl-carrier-protein S-malonyltransferase I 
Bmul2098_at Bmul_2098 1,3 - transcriptional regulator, BadM/Rrf2 family K 
Bmul2143_at Bmul_2143 1,3 - hypothetical protein S 
Bmul2165_a_at Bmul_2165 1,3 nagZ Beta-N-acetylhexosaminidase G 
Bmul2205_a_at Bmul_2205 1,5 creA hypothetical protein S 
Bmul2210_at Bmul_2210 1,3 - hypothetical protein - 
Bmul2266_a_at Bmul_2266 1,3 ubiG ubiquinone biosynthesis O-methyltransferase H 
Bmul2372_at Bmul_2372 1,5 - transcriptional regulator, GntR family K 
Bmul2373_at Bmul_2373 1,3 gatA amidase J 
Bmul2491_at Bmul_2491 1,3 ureE UreE urease accessory domain protein O 
Bmul2751_at Bmul_2751 1,4 - protein of unknown function DUF558 S 
Bmul2818_at Bmul_2818 1,5 pilB type II secretion system protein E NU 
Bmul2960_at Bmul_2960 1,3 - alpha/beta hydrolase fold R 
Bmul3009_at Bmul_3009 1,3 flgL flagellar hook-associated protein 3 N 
Bmul3017_at Bmul_3017 1,3 flgE flagellar basal body FlaE domain protein N 
Bmul3018_at Bmul_3018 1,3 flgD flagellar hook capping protein N 
Bmul3021_a_at Bmul_3021 1,7 flgA flagellar basal body P-ring biosynthesis protein FlgA  NO 
Bmul3022_at Bmul_3022 1,3 flgM anti-sigma-28 factor, FlgM KNU 
Bmul3051_at Bmul_3051 1,5 - putative signal transduction histidine kinase T 
Bmul3056_at Bmul_3056 1,3 fhlB putative flagellar protein FhlB N 
Bmul3151_at Bmul_3151 1,3 - hypothetical protein - 
Bmul3239_at Bmul_3239 1,3 benB benzoate 1,2-dioxygenase, small subunit Q 
Bmul3342_at Bmul_3342 1,5 - hypothetical protein M 
Bmul3362_at Bmul_3362 1,3 era methyl-accepting chemotaxis sensory transducer NT 
Bmul3417_at Bmul_3417 1,3 - hypothetical protein - 
Bmul3423_at Bmul_3423 1,4 - hypothetical protein P 
Bmul3719_at Bmul_3719 1,3 puuB FAD dependent oxidoreductase E 
Bmul3760_at Bmul_3760 1,3 - YCII-related protein S 
Bmul4080_at Bmul_4080 1,3 - hypothetical protein O 
Bmul4128_at Bmul_4128 1,4 marC multiple antibiotic resistance (MarC)-related protein U 
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Bmul4254_at Bmul_4254 1,3 - UspA domain protein T 
Bmul4369_at Bmul_4369 1,3 hpaH 2-oxo-hepta-3-ene-1,7-dioic acid hydratase Q 
Bmul4461_at Bmul_4461 1,3 - helix-hairpin-helix DNA-binding class 1 L 
Bmul4546_at Bmul_4546 1,3 coxS (2Fe-2S)-binding domain protein C 
Bmul4688_at Bmul_4688 1,4 - hypothetical protein - 
Bmul4932_at Bmul_4932 1,3 - hypothetical protein - 
Bmul5043_at Bmul_5043 1,4 - hypothetical protein R 
Bmul5086_at Bmul_5086 1,3 amiE amidase J 
Bmul5144_at Bmul_5144 1,3 - hypothetical protein R 
Bmul5155_at Bmul_5155 1,3 - hypothetical protein - 
Bmul5248_at Bmul_5248 1,4 ndh FAD-dependent pyridine nucleotide-disulphide 
oxidoreductase 
C 
Bmul5470_at Bmul_5470 1,4 - hypothetical protein - 
Bmul5907_at Bmul_5907 1,3 - hypothetical protein C 
Bmul6064_at Bmul_6064 1,3 - OsmC family protein O 
*LB-FC, lower bound of fold-change; 
 
 
 
Table A3. Complete list of B. multivorans ATCC17616 nonmucoid variant genes with decreased 
expression (>1.3-fold-change lower confidence bound) compared to the expression of the mucoid isolate. 
Probe set Locus Tag 
LB-
FC* 
Gene 
name Description COG 
BCAL2038_a_at Bmul_1309 -1,3 alc allantoicase  F 
BCAL2616_a_at Bmul_0879 -1,5 glnB nitrogen regulatory protein P-II  E 
Bmul0157_at Bmul_0157 -2,1 aqpZ hypothetical protein G 
Bmul0190_x_at Bmul_0190 -1,4 - histone family protein nucleoid-structuring protein H-NS R 
Bmul0354_at Bmul_0354 -1,4 - hypothetical protein - 
Bmul0389_x_at Bmul_0389 -1,5 - hypothetical protein - 
Bmul0542_at Bmul_0542 -1,7 - phasin family protein - 
Bmul0646_a_at Bmul_0646 -1,4 - integrase family protein L 
Bmul1072_at Bmul_1072 -1,7 - hypothetical protein P 
Bmul1318_a_at Bmul_1318 -1,4 mscL large conductance mechanosensitive channel protein M 
Bmul1393_x_at Bmul_1393 -1,8 - peptidoglycan-binding LysM S 
Bmul1606_at Bmul_1606 -1,7 orbS RNA polymerase, sigma-24 subunit, ECF subfamily K 
Bmul1610_at Bmul_1610 -1,9 fimC hypothetical protein NU 
Bmul1611_at Bmul_1611 -1,4 fimD hypothetical protein NU 
Bmul1612_at Bmul_1612 -2,8 fimA hypothetical protein NU 
Bmul1736_at Bmul_1736 -1,8 - Flp/Fap pilin component U 
Bmul1880_at Bmul_1880 -1,8 - hypothetical protein - 
Bmul1958_at Bmul_1958 -3,3 - hypothetical protein - 
Bmul1984_at Bmul_1984 -1,3 - hypothetical protein - 
Bmul1987_at Bmul_1987 -1,5 - hypothetical protein - 
Bmul2000_at Bmul_2000 -1,6 - hypothetical protein - 
Bmul2001_at Bmul_2001 -1,7 - CsbD family protein S 
Bmul2002_at Bmul_2002 -2,8 - hypothetical protein - 
Bmul2003_at Bmul_2003 -2,1 katE catalase P 
Bmul2004_at Bmul_2004 -1,4 - hemerythrin HHE cation binding domain protein - 
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Bmul2393_x_at Bmul_2393 -2,7 cspA cold-shock DNA-binding domain protein K 
Bmul2557_at Bmul_2557 -2,3 - transcriptional regulator, LysR family K 
Bmul2606_at Bmul_2606 -1,4 - protein of unknown function DUF23 - 
Bmul2607_at Bmul_2607 -1,4 - ABC transporter related GM 
Bmul2608_at Bmul_2608 -1,4 - ABC-2 type transporter GM 
Bmul2649_at Bmul_2649 -1,3 hmpA oxidoreductase FAD/NAD(P)-binding domain protein C 
Bmul2816_at Bmul_2816 -1,3 - hypothetical protein - 
Bmul2885_at Bmul_2885 -1,4 - hypothetical protein - 
Bmul2905_at Bmul_2905 -1,8 - hypothetical protein - 
Bmul2916_at Bmul_2916 -1,3 - hypothetical protein - 
Bmul2917_at Bmul_2917 -1,3 - hypothetical protein - 
Bmul2923_at Bmul_2923 -1,3 bcsE type VI secretion-associated protein, ImpA family S 
Bmul2927_x_at Bmul_2927 -1,3 bcsI type VI secretion system lysozyme-related protein S 
Bmul2928_a_at Bmul_2928 -1,4 bcsJ type VI secretion system effector, Hcp1 family S 
Bmul2929_a_at Bmul_2929 -1,5 bcsK type VI secretion protein, EvpB/VC_A0108 family S 
Bmul2930_x_at Bmul_2930 -1,9 bcsL type VI secretion protein, VC_A0107 family S 
Bmul2931_at Bmul_2931 -1,5 - hypothetical protein S 
Bmul2962_at Bmul_2962 -1,3 - transcriptional regulator, LysR family K 
Bmul2986_at Bmul_2986 -1,4 - hypothetical protein - 
Bmul2990_at Bmul_2990 -1,3 potD hypothetical protein E 
Bmul3279_at Bmul_3279 -1,3 - histone family protein nucleoid-structuring protein H-NS R 
Bmul3335_at Bmul_3335 -1,3 - hypothetical protein P 
Bmul3336_at Bmul_3336 -1,3 - hypothetical protein P 
Bmul3337_at Bmul_3337 -1,3 hmuS haemin-degrading family protein P 
Bmul3471_at Bmul_3471 -1,4 - diguanylate phosphodiesterase T 
Bmul3645_at Bmul_3645 -1,5 - hypothetical protein - 
Bmul3695_at Bmul_3695 -1,4 - hypothetical protein S 
Bmul3701_at Bmul_3701 -1,4 ldcC lysine decarboxylase E 
Bmul3702_at Bmul_3702 -1,3 adiC amino acid permease-associated region E 
Bmul3708_at Bmul_3708 -5,1 - hypothetical protein - 
Bmul3709_a_at Bmul_3709 -2,4 adh hemolysin-type calcium-binding region - 
Bmul3735_at Bmul_3735 -2,0 - hypothetical protein - 
Bmul3736_at Bmul_3736 -1,3 - natural resistance-associated macrophage protein P 
Bmul3737_at Bmul_3737 -1,3 - transcriptional regulator, LuxR family TK 
Bmul3806_at Bmul_3806 -1,3 - histone family protein nucleoid-structuring protein H-NS R 
Bmul4078_at Bmul_4078 -1,9 - hypothetical protein - 
Bmul4079_at Bmul_4079 -2,4 mgtA magnesium-translocating P-type ATPase P 
Bmul4115-2_at Bmul_4115 -1,4 - hypothetical protein S 
Bmul4295_at Bmul_4295 -1,3 - hypothetical protein K 
Bmul4389_at Bmul_4389 -1,7 - putative transcriptional regulator, Crp/Fnr family T 
Bmul4401_at Bmul_4401 -1,3 - glycosyl transferase group 1 M 
Bmul4408_at Bmul_4408 -1,5 - lipopolysaccharide biosynthesis protein D 
Bmul4502_at Bmul_4502 -1,4 - ABC transporter related E 
Bmul4711_at Bmul_4711 -1,3 - hypothetical protein - 
Bmul4712_at Bmul_4712 -1,6 - hypothetical protein - 
Bmul4822_x_at Bmul_4822 -1,3 xseB exodeoxyribonuclease VII, small subunit L 
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Bmul4921_at Bmul_4921 -1,4 - hypothetical protein L 
Bmul4936_at Bmul_4936 -1,3 - transcriptional regulator, AraC family K 
Bmul4947_at Bmul_4947 -1,5 - response regulator signal transduction histidine kinase T 
Bmul5003_a_at Bmul_5003 -1,3 - hypothetical protein E 
Bmul5122_a_at Bmul_5122 -1,5 - diguanylate cyclase/phosphodiesterase T 
Bmul5639_at Bmul_5639 -1,4 - alcohol dehydrogenase zinc-binding domain protein CR 
Bmul5655_at Bmul_5655 -1,4 - histone family protein nucleoid-structuring protein H-NS R 
Bmul5656_at Bmul_5656 -1,4 - hypothetical protein - 
Bmul5728_at Bmul_5728 -1,3 - hypothetical protein - 
Bmul5730_at Bmul_5730 -1,4 - type VI secretion system Vgr family protein S 
Bmul5751_at Bmul_5751 -1,4 - hypothetical protein V 
Bmul5760_at Bmul_5760 -1,3 - hypothetical protein C 
Bmul5761_at Bmul_5761 -1,3 coxA hypothetical protein C 
Bmul5763_at Bmul_5763 -1,4 - hypothetical protein - 
Bmul5766_at Bmul_5766 -1,3 - two component transcriptional regulator, LuxR family TK 
Bmul5767_at Bmul_5767 -1,9 - histone family protein nucleoid-structuring protein H-NS R 
Bmul5769_at Bmul_5769 -3,1 - hypothetical protein - 
Bmul5770_at Bmul_5770 -1,3 - protein of unknown function DUF125 transmembrane S 
Bmul5771_at Bmul_5771 -1,4 - hypothetical protein - 
Bmul5941_at Bmul_5941 -1,8 - hypothetical protein - 
Bmul5942_at Bmul_5942 -2,3 idi isopentenyl-diphosphate delta-isomerase, type 1 I 
Bmul5943_at Bmul_5943 -2,5 dxs deoxyxylulose-5-phosphate synthase HI 
Bmul5944_at Bmul_5944 -6,6 - methyltransferase type 12 M 
Bmul5945_at Bmul_5945 -4,8 - methyltransferase type 12 M 
Bmul5946_at Bmul_5946 -3,0 - rieske (2Fe-2S) domain protein PR 
Bmul5947_at Bmul_5947 -2,2 - hypothetical protein - 
Bmul5948_at Bmul_5948 -1,7 - cytochrome P450 Q 
Bmul5949_at Bmul_5949 -1,4 - rieske (2Fe-2S) domain protein PR 
Bmul6209_at Bmul_6209 -1,3 - hypothetical protein - 
*LB-FC, lower bound of fold-change; 
 
 
